<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /Users/grace/grobid-0.6.1/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2020-09-22">22 September 2020</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Elena</forename><surname>Obrador</surname></persName>
							<email>elena.obrador@uv.es</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Odontology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<addrLine>Av. Blasco Ibañez</addrLine>
									<postCode>4601016</postCode>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rosario</forename><surname>Salvador</surname></persName>
							<email>rosario.salvador@uv.es</email>
							<idno type="ORCID">0000-0002-0784-6776</idno>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Odontology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<addrLine>Av. Blasco Ibañez</addrLine>
									<postCode>4601016</postCode>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rafael</forename><surname>López-Blanch</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Odontology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<addrLine>Av. Blasco Ibañez</addrLine>
									<postCode>4601016</postCode>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ali</forename><surname>Jihad-Jebbar</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Odontology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<addrLine>Av. Blasco Ibañez</addrLine>
									<postCode>4601016</postCode>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Soraya</forename><forename type="middle">L</forename><surname>Vallés</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Odontology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<addrLine>Av. Blasco Ibañez</addrLine>
									<postCode>4601016</postCode>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">José</forename><forename type="middle">M</forename><surname>Estrela</surname></persName>
							<email>jose.m.estrela@uv.es</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Physiology</orgName>
								<orgName type="department" key="dep2">Faculty of Medicine and Odontology</orgName>
								<orgName type="institution">University of Valencia</orgName>
								<address>
									<addrLine>Av. Blasco Ibañez</addrLine>
									<postCode>4601016</postCode>
									<settlement>Valencia</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Oxidative Stress, Neuroinflammation and Mitochondria in the Pathophysiology of Amyotrophic Lateral Sclerosis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2020-09-22">22 September 2020</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.3390/antiox9090901</idno>
					<note type="submission">Received: 29 August 2020; Accepted: 20 September 2020;</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.1" ident="GROBID" when="2021-09-14T02:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>amyotrophic lateral sclerosis</term>
					<term>motor neuron disease</term>
					<term>neuroinflammation</term>
					<term>oxidative stress</term>
					<term>mitochondria</term>
				</keywords>
			</textClass>
			<abstract>
				<p>Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron (MN) disease. Its primary cause remains elusive, although a combination of different causal factors cannot be ruled out. There is no cure, and prognosis is poor. Most patients with ALS die due to disease-related complications, such as respiratory failure, within three years of diagnosis. While the underlying mechanisms are unclear, different cell types (microglia, astrocytes, macrophages and T cell subsets) appear to play key roles in the pathophysiology of the disease. Neuroinflammation and oxidative stress pave the way leading to neurodegeneration and MN death. ALS-associated mitochondrial dysfunction occurs at different levels, and these organelles are involved in the mechanism of MN death. Molecular and cellular interactions are presented here as a sequential cascade of events. Based on our present knowledge, the discussion leads to the idea that feasible therapeutic strategies should focus in interfering with the pathophysiology of the disease at different steps.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">Introduction</head><p>Amyotrophic lateral sclerosis (ALS), the most common motor neuron (MN) disease, is considered a rare disease based on its prevalence (2-3 cases per 100,000 people with European ancestry). The mean age of onset is 50-65 years, with only 5% of cases manifesting at 30 years or younger. In the younger patients, male predominate <ref type="bibr" target="#b0">[1]</ref>. Mean survival from the first symptom is 3-5 years, although about 10% of patients live longer than 10 years <ref type="bibr" target="#b1">[2]</ref>.</p><p>The cause is unknown in 90-95% of all cases (sporadic ALS (SALS)), and just 5-10% of cases are associated with known genetic mutations (familial-type ALS (FALS)) <ref type="bibr" target="#b2">[3]</ref>. More than 30 different genes have been linked to FALS <ref type="bibr" target="#b3">[4]</ref>. However, the most common mutations are found in C9orf72, SOD1, FUS, or TARDBP. These represent approximately 40%, 20%, 1-5%, and 2-5% of FALS cases, respectively <ref type="bibr" target="#b4">[5]</ref>.</p><p>In the absence of a family history of the disease, there is no known cause of ALS. Nevertheless, the involvement of many possible causal/risk factors has been suggested. This includes (but not limited to) chemicals, metals, radiation/electromagnetic fields, physical activity, dietary habits, viruses, bacteria, prions, fungi, protein-related abnormalities, mitochondria-related pathology, glutamate excitotoxicity, higher energy expenditure than intake and progressive impairment of glucose metabolism, microtubule mediated deficits in axonal transport, reactive phenotypes in astrocytes and microglia, autoimmunity, and moderate to severe traumatic brain injury <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref> Antioxidants 2020, 9, of 16 key anti-inflammatory factors that sustain MN viability. However, as the disease progresses and MN injury accelerates, a second rapidly-progressing phase develops, that is characterized by increased levels of M1 macrophages/microglia, and proinflammatory Th1 and Th17 T cells <ref type="bibr" target="#b28">[29]</ref>. It has been suggested that the neuroprotective M2/Treg/Th2-mediated pathways are downregulated whereas the cytotoxic M1/Th1/Th17 pathways are upregulated, resulting in a self-propagating proinflammatory acceleration of disease progression <ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref>.</p><p>Neuroinflammation and oxidative stress (OS) are inextricably linked in the pathogenesis of neurodegenerative diseases. OS is the consequence of increased production of reactive oxygen species (ROS), which is frequently accompanied by a decrease in antioxidant defenses <ref type="bibr" target="#b34">[35]</ref>. Glial and infiltrated immune cells are considered among the major producers of ROS and reactive nitrogen species (RNS) in pathological conditions of the CNS <ref type="bibr" target="#b35">[36]</ref>. Although ROS are not believed to cause ALS, they are likely to exacerbate disease progression <ref type="bibr" target="#b16">[17]</ref>.</p><p>OS may also contribute to the degeneration of the neuromuscular junction in ALS. Increased sensitivity of the nerve terminal to ROS has been shown in ALS mouse models, which may facilitate presynaptic decline in neuromuscular junctions. Moreover, excitatory amino acid-mediated overstimulation of MNs results in abnormal secretion of acetylcholinesterase, which will decrease the acetylcholine present in the synaptic cleft (a mechanism that could be behind the loss of muscle strength observed in ALS patients). These early-stage dysfunctions are accompanied by inflammatory agents and loss of trophic support, which ultimately may lead to neurodegeneration <ref type="bibr" target="#b36">[37]</ref>.</p><p>There is also evidence that the response to OS is dampened in ALS. Levels of glutathione (GSH), a prevalent antioxidant in mammalian cells, are lower in the motor cortex of ALS patients as compared to healthy volunteers <ref type="bibr" target="#b37">[38,</ref><ref type="bibr" target="#b38">39]</ref>. Moreover, expression of mutant TDP-43 in a MN-like cell line induces OS and mitochondrial damage eliciting nuclear accumulation of nuclear factor E2-related factor 2 (Nrf2), a master regulator of detoxification and also of antioxidant, anti-inflammatory and other cytoprotective mechanisms <ref type="bibr" target="#b39">[40,</ref><ref type="bibr" target="#b40">41]</ref>. Dysregulated Nrf2-dependent antioxidant pathways have been implicated in ALS, and therapeutic strategies targeting the Nrf2 antioxidant response element are under investigation <ref type="bibr" target="#b41">[42]</ref>. Nrf2 mRNA and protein levels are depleted in post-mortem tissues from ALS patients <ref type="bibr" target="#b41">[42]</ref>, and studies in ALS mouse models have shown a significant beneficial effect of elevated Nrf2 levels in astrocytes, the major GSH suppliers for neighboring neurons <ref type="bibr" target="#b42">[43]</ref>, Furthermore, Nrf2 signaling is critical for attenuating neuroinflammation in ALS through repression of the deleterious effects of activated microglia on neurons <ref type="bibr" target="#b43">[44]</ref>.</p><p>From all this evidence, we can conclude that neuroinflammation and OS are intertwined mechanisms involved in the physiopathology of ALS.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Mitochondria and the Mechanism of Motor Neuron Death</head><p>Mitochondrial dysfunction has also been implicated as a key neuropathological hallmark of ALS <ref type="bibr" target="#b11">[12]</ref>. For instance, reduction of the activity of the electron transport chain complexes (complex I-IV) in post-mortem spinal cord specimens from SALS patients <ref type="bibr" target="#b44">[45]</ref>, reduced intracellular ATP levels in lymphocytes of ALS patients <ref type="bibr" target="#b45">[46]</ref>, or inhibition of the voltage-dependent anion channel (VDAC) by mutant SOD1 <ref type="bibr" target="#b46">[47]</ref>.</p><p>The class III deacetylases, or sirtuins (SIRT), are a family of conserved epigenetic mediators that regulate a myriad of cellular processes relating to health-and life-span. Three of the seven known SIRT (SIRT3, SIRT4 and SIRT5) are primarily localized to the mitochondria <ref type="bibr" target="#b47">[48]</ref>.</p><p>SIRT3 has been extensively studied for its role in energy homeostasis. In addition to deacetylating and regulating several mitochondrial enzymes (such as acetyl-CoA synthase 2 and glutamate dehydrogenase, SIRT3 has been shown to regulate the production of mitochondrial ROS <ref type="bibr" target="#b48">[49]</ref>.</p><p>SIRT1 is primarily nuclear and has been shown to regulate longevity by maintaining mitochondrial homeostasis and mitophagy. Interestingly, intraperitoneal injection (but not oral administration) of resveratrol, a potential SIRT1 activator, led to a significant improvement in both symptoms and survival in the SOD1 G93A mouse model of ALS <ref type="bibr" target="#b49">[50]</ref>. This is consistent with recent findings where overexpression of SIRT1 in MN of SOD1 G93A mice delays the onset of the disease and increases survival <ref type="bibr" target="#b50">[51]</ref>. Moreover, SIRT1 may have wide-reaching implications on mitochondrial biogenesis via the deacetylation of PGC-1α <ref type="bibr" target="#b51">[52]</ref>. PGC-1α is downregulated in SALS patients <ref type="bibr" target="#b52">[53]</ref>. A decrease in PGC-1α associates with lower expression of SIRT3, a regulator of mitochondrial energy metabolism and ROS that is regulated by PGC-1α <ref type="bibr" target="#b53">[54]</ref>. Overexpression of SIRT3 in cultured cells increases respiration and PGC-1α expression, and decreases the production of ROS <ref type="bibr" target="#b53">[54,</ref><ref type="bibr" target="#b54">55]</ref>. Furthermore, overexpression of SIRT3 and PGC-1α protects against mitochondrial fragmentation and death in SOD1 G93A MNs <ref type="bibr" target="#b53">[54]</ref>. Moreover, SIRT3 deficiency results in hyperacetylation of SOD2 and cyclophilin D, two mitochondrial proteins involved in regulating adaptive responses of neurons to physiological challenges and resistance to degeneration. SIRT3 was also shown to regulate ketone body production by deacetylating mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2. This evidence is consistent with the elevation of mitochondrial SIRT3 expression in medium chain triglyceride-treated primary MN cultures and in the spinal cord of SOD1 G93A mice following medium chain triglyceride treatment <ref type="bibr" target="#b55">[56]</ref>. The authors hypothesize that medium chain triglycerides might regulate mitochondrial activity and cell survival through sirtuin-mediated responses.</p><p>Consumption of NAD + without an adequate method of replenishment can result in decreased activity of SIRT-dependent processes, and a consequential deleterious effect on mitochondrial biogenesis, function and mitophagy <ref type="bibr" target="#b47">[48]</ref>. Thus, SIRT deactivation may contribute to the mitochondrial dysfunction associated with ALS. Indeed, it has been shown that methods to enhance NAD + salvage pathways were able to attenuate the neurotoxic phenotype of SOD1 G93A astrocytes; this observation was most likely due to increased SIRT1 and SIRT3 activities associated with greater NAD + availability <ref type="bibr" target="#b56">[57]</ref>. Thus, methods to increase SIRT activity, by restoring NAD + levels or via direct activation using small molecules, are potential therapeutic approaches in the treatment of ALS.</p><p>A recent human pilot study <ref type="bibr" target="#b57">[58]</ref>, demonstrating that the experimental therapeutic EH301 may be able to slow the progressive decline in functionality, strength and lung function, may offer new insight into the pathophysiology underpinning ALS. EH301 is a combination of nicotinamide riboside (NR) and pterostilbene (PT); compounds that are predicted to increase availability of the coenzyme NAD + and support the activity of the SIRT and their downstream targets.</p><p>NR, a pyridine-nucleoside form of vitamin B3, is a precursor to NAD + with superior pharmacokinetic profile relative to other forms of B3 (nicotinic acid and nicotinamide) <ref type="bibr" target="#b58">[59]</ref>. Since NAD + depletion associates with neuronal death <ref type="bibr" target="#b59">[60]</ref>, it has been proposed that increasing NAD + availability may be neuroprotective <ref type="bibr" target="#b60">[61]</ref>. Gerdts et al. demonstrated, using a model of sterile alpha and TIR motif-constraining 1 (SARM1)-induced axonal death, that NAD + levels are rapidly depleted following axonal injury <ref type="bibr" target="#b61">[62]</ref>. Treatment with NR was shown to prevent axonal degeneration and cell death in this model.</p><p>Additionally, two modes of operation by isolated mitochondria result in significant O 2</p><p>•− production, predominantly from complex I: (i) when the mitochondria are not making ATP and consequently have a high ∆p (protonmotive force) and a reduced CoQ (coenzyme Q) pool; and (ii) when there is a high NADH/NAD + ratio in the mitochondrial matrix. For mitochondria that are actively making ATP, and consequently have a lower ∆p and NADH/NAD + ratio, the extent of O 2</p><p>•− production is far lower <ref type="bibr" target="#b62">[63]</ref>. NAD + -derived nicotinamide suppresses O 2</p><p>•− generation via reduction of electron transport and increases membrane potential (∆ψm) via downregulation of mitochondrial permeability transition pore (mtPTP) formation <ref type="bibr" target="#b63">[64]</ref>. PT (3,5-dimethoxy-4 -hydroxystilbene) is a naturally occurring stilbenoid, found primarily in blueberries and Pterocarpus marsupium heartwood. PT is a dimethylated analogue of resveratrol; a SIRT1-activating molecule that has been shown to increase lifespan in different model organisms <ref type="bibr" target="#b64">[65]</ref>. Han et al. reported delayed disease onset and increased survival in resveratrol-treated SOD1 G93A mice <ref type="bibr" target="#b49">[50]</ref>. The authors suggested that the therapeutic benefits of resveratrol may be due to increased SIRT1 activation, which was measured via deacetylation of p53 (a major SIRT1 substrate). Mancuso et al. and Song et al. also reported delayed disease onset, extended survival and improved spinal motor neuron function in SOD1 G93A mice, and both authors noted increased SIRT1 activation in the spinal cord <ref type="bibr" target="#b65">[66,</ref><ref type="bibr" target="#b66">67]</ref>. However the low bioavailability of this polyphenol has limited its translation into the clinical setting <ref type="bibr" target="#b64">[65]</ref>. PT substitutes two hydroxyl groups in resveratrol for methoxy groups, modifications that increase PT's lipophicity and half-life. PT can cross the blood brain barrier and has been shown to increase nuclear Nrf2, thus potentially promoting the antioxidant defenses in the CNS <ref type="bibr" target="#b67">[68]</ref>. Interestingly, PT has also been shown to attenuate early brain injury following subarachnoid hemorrhage via inhibition of the nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and NOX2-related OS <ref type="bibr" target="#b68">[69]</ref>. Which may further support the therapeutic role of PT in ALS, since the microglial NLRP3 inflammasome is activated by ALS proteins <ref type="bibr" target="#b69">[70]</ref>. <ref type="figure" target="#fig_0">Figure 1</ref> displays an integrated scheme of the molecular interactions underlying the potential benefits exerted by the combination of NR and PT. mtGSH depletion (either by oxidation or by inhibition of its transport) can promote the release of proapoptotic signals to the cytosol <ref type="bibr" target="#b70">[71]</ref>. In this regard Mytilineou et al. provided evidence that neuronal GSH depletion in the presence of glial cells leads to neuronal degeneration <ref type="bibr" target="#b71">[72]</ref>.</p><formula xml:id="formula_0">Antioxidants 2020, 9, x FOR PEER REVIEW 5 of 15</formula><p>cord <ref type="bibr" target="#b65">[66,</ref><ref type="bibr" target="#b66">67]</ref>. However the low bioavailability of this polyphenol has limited its translation into the clinical setting <ref type="bibr" target="#b64">[65]</ref>. PT substitutes two hydroxyl groups in resveratrol for methoxy groups, modifications that increase PT's lipophicity and half-life. PT can cross the blood brain barrier and has been shown to increase nuclear Nrf2, thus potentially promoting the antioxidant defenses in the CNS <ref type="bibr" target="#b67">[68]</ref>. Interestingly, PT has also been shown to attenuate early brain injury following subarachnoid hemorrhage via inhibition of the nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and NOX2-related OS <ref type="bibr" target="#b68">[69]</ref>. Which may further support the therapeutic role of PT in ALS, since the microglial NLRP3 inflammasome is activated by ALS proteins <ref type="bibr" target="#b69">[70]</ref>. <ref type="figure" target="#fig_0">Figure 1</ref> displays an integrated scheme of the molecular interactions underlying the potential benefits exerted by the combination of NR and PT. mtGSH depletion (either by oxidation or by inhibition of its transport) can promote the release of proapoptotic signals to the cytosol <ref type="bibr" target="#b70">[71]</ref>. In this regard Mytilineou et al. provided evidence that neuronal GSH depletion in the presence of glial cells leads to neuronal degeneration <ref type="bibr" target="#b71">[72]</ref>. Molecular interactions underlying the effect of nicotinamide riboside (NR) and pterostilbene (PT) in amyotrophic lateral sclerosis (ALS). SIRT1, sirtuin 1; SIRT3, sirtuin 3; HSPs, heat-shock proteins; HSF1, heat-shock factor 1; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; FOXO1, forkhead box protein O1; PARP, poly (ADP-ribose) polymerase; PGC1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; LXRs, liver X receptors; eNOS endothelial nitric oxide synthase; PPARα, peroxisome proliferator-activated receptors alpha; Nrf2/ARE, transcription factor Nrf2 (NF-E2-related factor 2)/antioxidant responsive element; ANT, adenine nucleotide translocator; SOD2, superoxide dismutase 2; NMDA, N-metil-D-aspartato; GSH, glutathione; TXN, thioredoxin. NR increases the availability of NAD + , which supports the activity of SIRT1 and SIRT3 and their downstream targets. PT activates SIRT1 and Nrf2. Activation of Nrf2 in MNs results in the induction of many cytoprotective proteins, i.e., (but are not limited to) the following: (1) GSH use and generation (γ-glutamyl-cysteine synthase, GSH reductase, xCT (a component of the cysteine/glutamate transporter), GSH peroxidase 2, different GSH transferase isoenzymes); (2) quinone detoxification (NAD(P)H dehydrogenase (quinone 1)); (3) thioredoxin use and generation (thioredoxin 1, peroxiredoxin 1, thioredoxin reductase 1); (4) iron sequestration (heme <ref type="figure" target="#fig_0">Figure 1</ref>. Molecular interactions underlying the effect of nicotinamide riboside (NR) and pterostilbene (PT) in amyotrophic lateral sclerosis (ALS). SIRT1, sirtuin 1; SIRT3, sirtuin 3; HSPs, heat-shock proteins; HSF1, heat-shock factor 1; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; FOXO1, forkhead box protein O1; PARP, poly (ADP-ribose) polymerase; PGC1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; LXRs, liver X receptors; eNOS endothelial nitric oxide synthase; PPARα, peroxisome proliferator-activated receptors alpha; Nrf2/ARE, transcription factor Nrf2 (NF-E2-related factor 2)/antioxidant responsive element; ANT, adenine nucleotide translocator; SOD2, superoxide dismutase 2; NMDA, N-metil-D-aspartato; GSH, glutathione; TXN, thioredoxin. NR increases the availability of NAD + , which supports the activity of SIRT1 and SIRT3 and their downstream targets. PT activates SIRT1 and Nrf2. Activation of Nrf2 in MNs results in the induction of many cytoprotective proteins, i.e., (but are not limited to) the following: The role of the adenine nucleotide translocator (ANT) in apoptosis is well known <ref type="bibr" target="#b79">[80]</ref> and, as part of the mechanisms linking apoptosis and ALS, the mtPTP has been implicated in the pathogenesis <ref type="bibr" target="#b80">[81]</ref>. The ANT forms the inner membrane channel of the mtPTP complex <ref type="bibr" target="#b81">[82]</ref>. In vitro cell experiments have shown that NO and ONOOcan act directly on the ANT to induce mitochondrial permeabilization <ref type="bibr" target="#b82">[83]</ref>. Interestingly the ANT and its regulator (cyclophiline D, CyPD) were found as targets of nitration in ALS mice <ref type="bibr" target="#b83">[84]</ref>. SOD1 G93A mice without CyPD (genetic ablation of the Ppif gene) showed markedly delayed disease onset and lived significantly longer than mice with CyPD <ref type="bibr" target="#b83">[84]</ref>. In ALS patients affected anterior horns of the spinal cord are depleted of large MN, whereas the remaining MN are partially atrophic <ref type="bibr" target="#b80">[81]</ref>. Cell death assays identified subsets of MN in the process of DNA fragmentation as the nucleus condenses and the cell body shrinks <ref type="bibr" target="#b80">[81]</ref>. Moreover, in ALS patients, p53 (which promotes apoptosis via the Apaf-1/caspase-9 pathway and involves mitochondrial cytochrome c release) <ref type="bibr" target="#b84">[85]</ref>, accumulates in the nucleus of MN. Based on these observations and related background a plausible model of the mechanism leading to apoptotic cell death in MN is displayed in <ref type="figure">Figure 2</ref>.</p><p>oxygenase 2); (5) NADPH generation (glucose-6-P dehydrogenase, phosphogluconate dehydrogenase, malic enzyme 1, isocitrate dehydrogenase 1) <ref type="bibr" target="#b41">[42,</ref><ref type="bibr" target="#b64">65,</ref><ref type="bibr" target="#b72">[73]</ref><ref type="bibr" target="#b73">[74]</ref><ref type="bibr" target="#b74">[75]</ref><ref type="bibr" target="#b75">[76]</ref><ref type="bibr" target="#b76">[77]</ref><ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref>.</p><p>The role of the adenine nucleotide translocator (ANT) in apoptosis is well known <ref type="bibr" target="#b79">[80]</ref> and, as part of the mechanisms linking apoptosis and ALS, the mtPTP has been implicated in the pathogenesis <ref type="bibr" target="#b80">[81]</ref>. The ANT forms the inner membrane channel of the mtPTP complex <ref type="bibr" target="#b81">[82]</ref>. In vitro cell experiments have shown that NO and ONOOcan act directly on the ANT to induce mitochondrial permeabilization <ref type="bibr" target="#b82">[83]</ref>. Interestingly the ANT and its regulator (cyclophiline D, CyPD) were found as targets of nitration in ALS mice <ref type="bibr" target="#b83">[84]</ref>. SOD1 G93A mice without CyPD (genetic ablation of the Ppif gene) showed markedly delayed disease onset and lived significantly longer than mice with CyPD <ref type="bibr" target="#b83">[84]</ref>. In ALS patients affected anterior horns of the spinal cord are depleted of large MN, whereas the remaining MN are partially atrophic <ref type="bibr" target="#b80">[81]</ref>. Cell death assays identified subsets of MN in the process of DNA fragmentation as the nucleus condenses and the cell body shrinks <ref type="bibr" target="#b80">[81]</ref>. Moreover, in ALS patients, p53 (which promotes apoptosis via the Apaf-1/caspase-9 pathway and involves mitochondrial cytochrome c release) <ref type="bibr" target="#b84">[85]</ref>, accumulates in the nucleus of MN. Based on these observations and related background a plausible model of the mechanism leading to apoptotic cell death in MN is displayed in <ref type="figure">Figure 2</ref>. <ref type="figure">Figure 2</ref>. Opening of the mtPTP complex preceding apoptotic motor neuron death during ALS pathophysiology. The voltage-dependent anion channel (VDAC) and mitochondrial adenine nucleotide translocator (ANT) are both dimers located in the outer and inner membranes, respectively. High membrane potential in normally functioning mitochondria keeps the mitochondrial permeability transition pore (mtPTP) closed. Under pathophysiological conditions such as oxidative/nitrosative stress, the mtPTP opens, allowing the entry of H2O and solutes. Thus, causing mitochondrial swelling and release of apoptosis-initiating factor (AIF) and cytochrome c from the intermembrane space (IMS), which ultimately results in apoptosis. ROS/RNS cause mtGSH depletion and, consequently, higher levels of intramitochondrial free Ca 2+ , oxidation of critical redoxsensitive -SH groups of the ANT (e.g., Cys56; which, under physiological conditions, are in equilibrium with matrix GSH), and decreased mitochondrial membrane potential. All these factors can trigger structural changes leading to the formation of the mtPTP complex. Translocator protein (TSPO), hexokinase (HK), creatine kinase (CK), and cyclophilin D (CypD) are the other components of mtPTP. Outer membrane (OM), inner membrane (IM).</p><p>Furthermore, it has been shown that nuclear protein TDP-43 (hyper-phosphorylated and ubiquitinated TDP-43 deposits act as inclusion bodies in the brain and spinal cord of SALS patients) also interacts with mitochondrial proteins critical for mitochondrial dynamics and mitophagy, including voltage-gated anion channel 1 (VDAC1) and prohibitin (PHB2), a crucial mitophagy receptor <ref type="bibr" target="#b85">[86]</ref>. Moreover, genetic studies (i.e., gene mutations affecting DCTN1, OPTN, TBK1, VCP, and C9ORF72) have implicated deficits in autophagy and/or mitophagy in the onset of the disease <ref type="bibr" target="#b86">[87]</ref>. Thus, it is plausible that altered selective sequestration and subsequent degradation of the dysfunctional mitochondrion, before it causes activation of cell death, may contribute to the irreversible death of MNs. In this regard, it has been reported that ALS-FTD-linked mutations of <ref type="figure">Figure 2</ref>. Opening of the mtPTP complex preceding apoptotic motor neuron death during ALS pathophysiology. The voltage-dependent anion channel (VDAC) and mitochondrial adenine nucleotide translocator (ANT) are both dimers located in the outer and inner membranes, respectively. High membrane potential in normally functioning mitochondria keeps the mitochondrial permeability transition pore (mtPTP) closed. Under pathophysiological conditions such as oxidative/nitrosative stress, the mtPTP opens, allowing the entry of H 2 O and solutes. Thus, causing mitochondrial swelling and release of apoptosis-initiating factor (AIF) and cytochrome c from the intermembrane space (IMS), which ultimately results in apoptosis. ROS/RNS cause mtGSH depletion and, consequently, higher levels of intramitochondrial free Ca 2+ , oxidation of critical redox-sensitive -SH groups of the ANT (e.g., Cys56; which, under physiological conditions, are in equilibrium with matrix GSH), and decreased mitochondrial membrane potential. All these factors can trigger structural changes leading to the formation of the mtPTP complex. Translocator protein (TSPO), hexokinase (HK), creatine kinase (CK), and cyclophilin D (CypD) are the other components of mtPTP. Outer membrane (OM), inner membrane (IM).</p><p>Furthermore, it has been shown that nuclear protein TDP-43 (hyper-phosphorylated and ubiquitinated TDP-43 deposits act as inclusion bodies in the brain and spinal cord of SALS patients) also interacts with mitochondrial proteins critical for mitochondrial dynamics and mitophagy, including voltage-gated anion channel 1 (VDAC1) and prohibitin 2 (PHB2), a crucial mitophagy receptor <ref type="bibr" target="#b85">[86]</ref>. Moreover, genetic studies (i.e., gene mutations affecting DCTN1, OPTN, TBK1, VCP, and C9ORF72) have implicated deficits in autophagy and/or mitophagy in the onset of the disease <ref type="bibr" target="#b86">[87]</ref>. Thus, it is plausible that altered selective sequestration and subsequent degradation of the dysfunctional mitochondrion, before it causes activation of cell death, may contribute to the irreversible death of MNs. In this regard, it has been reported that ALS-FTD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NRF2-dependent anti-OS mechanisms <ref type="bibr" target="#b87">[88]</ref>. Which further suggests links between autophagy/mitophagy and OS in the pathophysiology of ALS.</p><p>The 'glutamate hypothesis', that implicates glutamate-induced cytotoxicity, remains a primary theory of the mechanism leading to MN death. Glutamate is synthesized from glutamine by the enzyme glutaminase. This can occur in the presynaptic neuron or in neighboring glial cells. The cytosolic concentration of glutamate in glutamatergic neurons is in the mM range <ref type="bibr" target="#b88">[89]</ref>. However, the intracellular glutamate concentration in the MNs of patients or mouse models of ALS under in vivo conditions is unknown; and it is also unknown if it is of any relevance. Glutamate is a competitive inhibitor of GSH transport into mitochondria <ref type="bibr" target="#b89">[90]</ref>, and mtGSH depletion and Ca 2+ load could initiate the cascade of events causing MN death, including mitochondrial dysfunction, oxidative/nitrosative stress-associated damage, formation of Ca 2+ -rich precipitates, and the release of proapoptotic signaling molecules to the cytosol <ref type="figure" target="#fig_3">(Figure 3)</ref>. Preliminary experiments performed in our lab show that MNs isolated from FUS R521C transgenic mice (which develop robust neuronal loss in the spinal cord, denervation of neuromuscular junctions, and muscle atrophy) <ref type="bibr" target="#b90">[91]</ref> show mtGSH depletion and higher cytosolic glutamate levels as compared to normal wild-type C57BL/6 mice <ref type="table" target="#tab_0">(Table 1)</ref>  <ref type="bibr">(Estrela et al., unpublished results)</ref>. This potential mechanism and the underlying metabolic adaptations, and whether apoptosis is the preferent type of MN death in ALS, are under investigation in our laboratories. <ref type="figure" target="#fig_3">Figure 3</ref> schematically outlines the main metabolite flows in the MN microenvironment.</p><p>Antioxidants 2020, 9, x FOR PEER REVIEW 7 of 15 SQSTM1/p62 disrupt selective autophagy and NRF2-dependent anti-OS mechanisms <ref type="bibr" target="#b87">[88]</ref>. Which further suggests links between autophagy/mitophagy and OS in the pathophysiology of ALS. The 'glutamate hypothesis', that implicates glutamate-induced cytotoxicity, remains a primary theory of the mechanism leading to MN death. Glutamate is synthesized from glutamine by the enzyme glutaminase. This can occur in the presynaptic neuron or in neighboring glial cells. The cytosolic concentration of glutamate in glutamatergic neurons is in the mM range <ref type="bibr" target="#b88">[89]</ref>. However, the intracellular glutamate concentration in the MNs of patients or mouse models of ALS under in vivo conditions is unknown; and it is also unknown if it is of any relevance. Glutamate is a competitive inhibitor of GSH transport into mitochondria <ref type="bibr" target="#b89">[90]</ref>, and mtGSH depletion and Ca 2+ load could initiate the cascade of events causing MN death, including mitochondrial dysfunction, oxidative/nitrosative stress-associated damage, formation of Ca 2+ -rich precipitates, and the release of proapoptotic signaling molecules to the cytosol <ref type="figure" target="#fig_3">(Figure 3)</ref>. Preliminary experiments performed in our lab show that MNs isolated from FUS R521C transgenic mice (which develop robust neuronal loss in the spinal cord, denervation of neuromuscular junctions, and muscle atrophy) <ref type="bibr" target="#b90">[91]</ref> show mtGSH depletion and higher cytosolic glutamate levels as compared to normal wild-type C57BL/6 mice <ref type="table" target="#tab_0">(Table 1)</ref>  <ref type="bibr">(Estrela et al., unpublished results)</ref>. This potential mechanism and the underlying metabolic adaptations, and whether apoptosis is the preferent type of MN death in ALS, are under investigation in our laboratories.  Fluxes of metabolites in the microenvironment of the motor neuron and the activation of mitochondria-dependent apoptosis. We can hypothesize that RNA-protein associations could theoretically be the starting point of protein misfolding leading to insoluble structures (e.g., of TDP-43) which could eventually associate to (and recruit) other native proteins. This progressive mechanism, which resembles the typical prion replication, may lead to the formation of abnormal protein complexes spreading (in the case of ALS) throughout the MN network. Interestingly some recent findings suggest that extracellular vesicles may facilitate the spread of toxic proteins and might play a role in the prion-like propagation of ALS disease <ref type="bibr" target="#b91">[92]</ref>. Nevertheless, a mechanism mediated by a (food related?) neurotoxin cannot be ruled out. Abnormal protein-or neurotoxin-induced alteration of the interaction between glutamate and its receptor could cause glutamate accumulation in the synaptic cleft (and also within the presynaptic glutamatergic neuron?). This accumulation could be <ref type="figure" target="#fig_3">Figure 3</ref>. Fluxes of metabolites in the microenvironment of the motor neuron and the activation of mitochondria-dependent apoptosis. We can hypothesize that RNA-protein associations could theoretically be the starting point of protein misfolding leading to insoluble structures (e.g., of TDP-43) which could eventually associate to (and recruit) other native proteins. This progressive mechanism, which resembles the typical prion replication, may lead to the formation of abnormal protein complexes spreading (in the case of ALS) throughout the MN network. Interestingly some recent findings suggest that extracellular vesicles may facilitate the spread of toxic proteins and might play a role in the prion-like propagation of ALS disease <ref type="bibr" target="#b91">[92]</ref>. Nevertheless, a mechanism mediated by a (food related?) neurotoxin cannot be ruled out. Abnormal protein-or neurotoxin-induced alteration of the interaction between glutamate and its receptor could cause glutamate accumulation in the synaptic cleft (and also within the presynaptic glutamatergic neuron?). This accumulation could be exacerbated by defects in astrocyte glutamate uptake due to loss of the EAAT2 transporter occurring in both SALS and FALS cases <ref type="bibr" target="#b92">[93,</ref><ref type="bibr" target="#b93">94]</ref>. In fact, glutamate induces far greater ROS generation in cultured MNs than in other spinal neurons. Hypothetically, in the MNs a glutamate-induced inhibition of GSH uptake by mitochondria coupled with proinflammatory cytokines, such as TNFα, could promote an increase in ROS, thereby leading to mitochondrial dysfunction and activation of cell death in a mechanism similar to that described in tumor cells <ref type="bibr" target="#b89">[90]</ref>. Activated microglia and astrocytes express and release high levels of TNFα <ref type="bibr" target="#b94">[95]</ref>; these events would then activate a (more intense) local inflammatory response involving T lymphocytes, activated microglia and macrophages. Inflammation-associated alteration of the ionic equilibrium would favor Ca 2+ influx, which would further promote mitochondrial dysfunction. Glutamate accumulation in the extracellular space would also affect cysteine uptake and, thereby, GSH synthesis in astrocytes and its export to neurons <ref type="bibr" target="#b95">[96]</ref>. Intracellular GSH depletion facilitates the release of Ca 2+ from intracellular deposits <ref type="bibr" target="#b96">[97]</ref>. ROS (and associated RNS) could also damage different transport mechanisms such as glucose transporters. ROS/RNS-induced protein damage would also favor the formation of protein aggregates and cause impaired axonal transport. Any exogenous pro-oxidative stress factor (e.g., radiations, metal toxicity, intense physical activity, or low intake of dietary antioxidants) could aggravate the progression of the disease. Moreover, as the disease progresses, nutritional deficiency, cachexia, psychological stress, and impending respiratory failure may further increase oxidative stress leading inexorably to MN death. GR, glutamate receptors; AMPAR, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; NMDAR, N-methyl-D-aspartate receptor; ROS/RNS, reactive oxygen and nitrogen species; GLUT1, glucose transporter 1; GLUT3, glucose transporter 3; MCT, lactate transporter; EATT, excitatory amino acid transporter; N and A, Gln transporters; Xc -, cysteine/glutamate antiporter; ASC, transport system for neutral amino acids; AP, Ca 2 + /Na + antiporter; GGT/DIP, γ-glutamyl transpeptidase and dipeptidases; mt, mitochondrial. PTP, permeability transition pore complex; G, glucose; Pyr, pyruvate; Lact, lactate; GSH, glutathione; Cys, cysteine; Gln, glutamine; Glu, glutamate. High yield extraction and culture of pure spinal motor neurons (MNs) were performed as previously described <ref type="bibr" target="#b97">[98]</ref>. Wild-type C57BL/6 and transgenic FUS R521C (expressing mutant FUS protein) mice were obtained from Jackson Labs. FUS R521C mice show, at postnatal day 60, about 50% loss of anterior horn neurons (remaining motor neurons show reduced dendritic complexity and synaptic density). MN isolation and measurements were performed at postnatal day 100. Cytosolic (cyt) and mitochondrial (mt) compartments were rapidly separated using digitonin and centrifugation through a layer of silicon oil, as previously described for other cell types <ref type="bibr" target="#b98">[99]</ref>. Measurement of H 2 O 2 based on the H 2 O 2 /horseradish peroxidase-dependent oxidation of homovanillic acid (3-methoxy-4-hydroxyphenylacetic acid) to a highly fluorescent dimer (2,2-dihydroxydiphenyl-5,5-diacetic acid) and flow cytometric determination of O 2 − generation were performed as previously described (a.u., arbitrary units) <ref type="bibr" target="#b99">[100]</ref>. Glutamate was measured fluorometrically by a standard enzymic method <ref type="bibr" target="#b100">[101]</ref>. Glutathione (GSH) and glutathione disulfide (GSSG) levels were determined by liquid chromatography-mass spectrometry as previously described <ref type="bibr" target="#b101">[102]</ref>. Free Ca 2+ levels were measured using the Ca 2+ indicator Fura-2 AM and following the methodology described by Abcam (Cambridge, UK). Results are expressed as means ± SD for 6-7 different experiments. * p &lt; 0.05, ** p &lt; 0.01 (Student's t-test) comparing MNs from FUS R521C versus their equivalent wild-type.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.">Implications in the Therapy of ALS</head><p>Riluzole (shown to compensate for harmful extracellular glutamate levels), currently prescribed to most ALS patients, has been found to improve survival by 2-3 months <ref type="bibr" target="#b102">[103]</ref>. In addition to its role in accelerating glutamate clearance from the synapse, riluzole may also prevent glutamate release from presynaptic terminals <ref type="bibr" target="#b103">[104]</ref> and therefore could favor pathophysiology <ref type="figure" target="#fig_3">(Figure 3)</ref>. Edaravone (an antioxidant) was approved for the treatment of ALS in the US in 2017 based on the results from a randomized placebo-controlled clinical trial in subjects with early-stage ALS in Japan (NCT01492686, www.clinicaltrials.gov). In this trial edaravone significantly slowed the 24-week decline in functionality, measured via the revised ALS functional rating scale (ALSFRS-R), in the edaravone-treated group relative to placebo (−5.01 compared to −7.50, respectively). However, edaravone has failed to demonstrate efficacy in two trials in patients with all stages of ALS, and may not be a viable treatment option for the wider patient population <ref type="bibr" target="#b104">[105,</ref><ref type="bibr" target="#b105">106]</ref>.</p><p>Other therapeutic approaches under consideration have been recently reviewed <ref type="bibr" target="#b106">[107]</ref> and include: (a) masitinib <ref type="bibr" target="#b107">[108]</ref> which demonstrated a 27% reduction in functional decline when administered along with riluzole in a 48-week placebo-controlled phase 3 trial. Masitinib, a tyrosine kinase inhibitor, is predicted to work by reducing microglia-based inflammation of MNs in the brain and spinal cord (NCT02588677, www.clinicaltrials.gov); (b) AMX0035, a combination of sodium phenylbutyrate and tauroursodeoxycholic acid, aimed to reduce nerve cell death by limiting cell death and neuroinflammation; (c) antisense therapy; (d) gene therapy; or (e) stem-cell therapy using mesenchymal stromal cells isolated from e.g., adipose tissue. Mesenchymal stromal cells secrete small proteins (e.g., neurotrophic factors) that support the survival of motor neurons and also support the immune system, which may be relevant given a role for the immune system and its associated inflammation in ALS. At present all other clinical procedures used in ALS patients are essentially palliative: breathing support, physical therapy, and end of life care.</p><p>Based on available evidences and the pathophysiology mechanisms described above, we might suggest other options to be also explored, i.e., therapeutic agents to control the intracellular glutamate cytotoxicity (e.g., necrostatin-1) <ref type="bibr" target="#b108">[109,</ref><ref type="bibr" target="#b109">110]</ref>; anti-inflammatory drugs <ref type="bibr" target="#b110">[111,</ref><ref type="bibr" target="#b111">112]</ref>; specific cannabinoid receptors such as CB2 (to improve neuroprotection) <ref type="bibr" target="#b112">[113]</ref>; metal chelators, e.g., the iron chelator deferiprone (to limit metal-induced toxicity leading to OS) <ref type="bibr" target="#b113">[114]</ref>; neurotrophins (to promote neuroplasticity) <ref type="bibr" target="#b114">[115]</ref>; cyclic nucleotide phosphodiesterase (PDE) inhibitors to prevent glial cell activation (e.g., ibudilast) <ref type="bibr" target="#b115">[116]</ref>; antiretrovirals (e.g., TRIUMEQ ® , a combination of abacavir sulfate, dolutegravir sodium, and lamivudine) used as an anti-HIV therapy, and based on the fact that ALS patients present serum concentrations of reverse transcriptase comparable to HIV-infected patients <ref type="bibr" target="#b116">[117]</ref>; antiepileptic drugs (e.g., retigabine, which acts by binding to the voltage-gated K + channels and increasing the M-current, thus leading to membrane hyperpolarization and decreasing excitability) <ref type="bibr" target="#b117">[118]</ref>; or the antiestrogen tamoxifen (some neurological improvements have been observed in ALS patients with breast cancer and treated with tamoxifen-an effect possibly related to the inhibition of protein kinase C, which is overexpressed in the spinal cord of ALS patients) (see e.g., NCT00214110 under www.clinicaltrials.gov).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Concluding Remarks</head><p>In light of recent evidences highlighting the therapeutic potential of sirtuin activation and NAD + repletion, a sequential cascade of events in the pathophysiology of ALS begins to be visualized.</p><p>Neuroinflammation, involving reactive astrocytes and microglia, and peripheral immune cells, promotes OS in the MN microenvironment. In this scenario many of the suggested causes/factors of SALS could be secondary, with the plausible exception of an infectious agent and/or an autoimmune mechanism. Neurodegeneration and the death of the MN would be the consequence of these initial phenomena. Experimental evidences suggest that damage to mitochondria could be a key mechanism involved in the final activation of neuronal death.</p><p>New therapeutic combinations could hopefully offer options to control the disease and extend the life expectancy of patients. In order to fulfil this aim, targeting patients early in their disease course may be critical. Finally, given the heterogeneity of disease progression, as well as key pathogenic differences according to disease stage, precision approaches combining genomics, biomarkers, imaging markers, and targeted/combined therapeutics may help to improve the clinical outcome.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Molecular interactions underlying the effect of nicotinamide riboside (NR) and pterostilbene (PT) in amyotrophic lateral sclerosis (ALS). SIRT1, sirtuin 1; SIRT3, sirtuin 3; HSPs, heat-shock proteins; HSF1, heat-shock factor 1; NF-kB, nuclear factor kappa-light-chain-enhancer of activated B cells; FOXO1, forkhead box protein O1; PARP, poly (ADP-ribose) polymerase; PGC1α, peroxisome proliferator-activated receptor gamma coactivator 1-alpha; LXRs, liver X receptors; eNOS endothelial nitric oxide synthase; PPARα, peroxisome proliferator-activated receptors alpha; Nrf2/ARE, transcription factor Nrf2 (NF-E2-related factor 2)/antioxidant responsive element; ANT, adenine nucleotide translocator; SOD2, superoxide dismutase 2; NMDA, N-metil-D-aspartato; GSH, glutathione; TXN, thioredoxin. NR increases the availability of NAD + , which supports the activity of SIRT1 and SIRT3 and their downstream targets. PT activates SIRT1 and Nrf2. Activation of Nrf2 in MNs results in the induction of many cytoprotective proteins, i.e., (but are not limited to) the following: (1) GSH use and generation (γ-glutamyl-cysteine synthase, GSH reductase, xCT (a component of the cysteine/glutamate transporter), GSH peroxidase 2, different GSH transferase isoenzymes); (2) quinone detoxification (NAD(P)H dehydrogenase (quinone 1)); (3) thioredoxin use and generation (thioredoxin 1, peroxiredoxin 1, thioredoxin reductase 1); (4) iron sequestration (heme</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>( 1 )</head><label>1</label><figDesc>GSH use and generation (γ-glutamyl-cysteine synthase, GSH reductase, xCT (a component of the cysteine/glutamate transporter), GSH peroxidase 2, different GSH transferase isoenzymes); (2) quinone detoxification (NAD(P)H dehydrogenase (quinone 1)); (3) thioredoxin use and generation (thioredoxin 1, peroxiredoxin 1, thioredoxin reductase 1); (4) iron sequestration (heme oxygenase 2); (5) NADPH generation (glucose-6-P dehydrogenase, phosphogluconate dehydrogenase, malic enzyme 1, isocitrate dehydrogenase 1)<ref type="bibr" target="#b41">[42,</ref><ref type="bibr" target="#b64">65,</ref><ref type="bibr" target="#b72">[73]</ref><ref type="bibr" target="#b73">[74]</ref><ref type="bibr" target="#b74">[75]</ref><ref type="bibr" target="#b75">[76]</ref><ref type="bibr" target="#b76">[77]</ref><ref type="bibr" target="#b77">[78]</ref><ref type="bibr" target="#b78">[79]</ref>.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>Figure 3schematically outlines the main metabolite flows in the MN microenvironment.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Fluxes of metabolites in the microenvironment of the motor neuron and the activation of mitochondria-dependent apoptosis. We can hypothesize that RNA-protein associations could theoretically be the starting point of protein misfolding leading to insoluble structures (e.g., of TDP-43) which could eventually associate to (and recruit) other native proteins. This progressive mechanism, which resembles the typical prion replication, may lead to the formation of abnormal protein complexes spreading (in the case of ALS) throughout the MN network. Interestingly some recent findings suggest that extracellular vesicles may facilitate the spread of toxic proteins and might play a role in the prion-like propagation of ALS disease [92]. Nevertheless, a mechanism mediated by a (food related?) neurotoxin cannot be ruled out. Abnormal protein-or neurotoxin-induced alteration of the interaction between glutamate and its receptor could cause glutamate accumulation in the synaptic cleft (and also within the presynaptic glutamatergic neuron?). This accumulation could be</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>ROS generation and levels of glutamate, GSH, GSSG and Ca 2+ in motor neurons isolated from wild-type (WT) and FUS R521C mice.</figDesc><table><row><cell></cell><cell></cell><cell></cell><cell cols="2">Motor Neurons</cell><cell></cell></row><row><cell></cell><cell></cell><cell>WT</cell><cell></cell><cell></cell><cell>FUS R521C</cell></row><row><cell></cell><cell>cyt</cell><cell>mt</cell><cell>Total</cell><cell>cyt</cell><cell>mt</cell><cell>Total</cell></row><row><cell>H 2 O 2 (nmol/10 6 cells•min)</cell><cell></cell><cell></cell><cell>0.42 ± 0.17</cell><cell></cell><cell></cell><cell>1.06 ± 0.33 **</cell></row><row><cell>O 2 •− (∆FL1, a.u.)</cell><cell></cell><cell></cell><cell>2.11 ± 0.66</cell><cell></cell><cell></cell><cell>4.33 ± 1.20 *</cell></row><row><cell>Glutamate (nmol/10 6 cells)</cell><cell>28.5 ± 4.3</cell><cell>5.6 ± 1.4</cell><cell></cell><cell>41.7 ± 5.9 **</cell><cell>7.2 ± 1.8</cell></row><row><cell>GSH (nmol/10 6 cells)</cell><cell>21.2 ± 2.9</cell><cell>4.3 ± 1.2</cell><cell></cell><cell>15.0 ± 2.4 **</cell><cell>2.1 ± 0.5 **</cell></row><row><cell>GSSG (nmol/10 6 cells)</cell><cell>0.5 ± 0.2</cell><cell>0.2 ± 0.05</cell><cell></cell><cell>1.0 ± 0.3 *</cell><cell>0.4 ± 0.1 **</cell></row><row><cell>Ca 2+ (nmol/mg protein)</cell><cell>1087 ± 184</cell><cell>512 ± 96</cell><cell></cell><cell>1740 ± 260 **</cell><cell>826 ± 160 *</cell></row></table><note></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of Interest:</head><p>The authors declare no conflict of interest.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Epidemiology of amyotrophic lateral sclerosis: A review of literature</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Couratier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Corcia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Lautrette</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Nicol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P.-M</forename><surname>Preux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Marin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neurol.2015.11.002</idno>
	</analytic>
	<monogr>
		<title level="j">Rev. Neurol</title>
		<imprint>
			<biblScope unit="volume">172</biblScope>
			<biblScope unit="page" from="37" to="45" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Couratier, P.; Corcia, P.; Lautrette, G.; Nicol, M.; Preux, P.-M.; Marin, B. Epidemiology of amyotrophic lateral sclerosis: A review of literature. Rev. Neurol. 2016, 172, 37-45. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Traxinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Lyles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Glass</surname></persName>
		</author>
		<idno type="DOI">10.1212/CPJ.0b013e3182a1b8ab</idno>
	</analytic>
	<monogr>
		<title level="j">Neurol. Clin. Pract</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="313" to="320" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Traxinger, K.; Kelly, C.; Johnson, B.A.; Lyles, R.H.; Glass, J.D. Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011. Neurol. Clin. Pract. 2013, 3, 313-320. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">What causes amyotrophic lateral sclerosis?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Khleifat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Al-Chalabi</surname></persName>
		</author>
		<idno type="DOI">10.12688/f1000research.10476.1</idno>
		<imprint>
			<date type="published" when="2017" />
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">371</biblScope>
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Martin, S.; Al Khleifat, A.; Al-Chalabi, A. What causes amyotrophic lateral sclerosis? F1000Research 2017, 6, 371. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Al-Chalabi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Van Den</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">H</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Veldink</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrneurol.2016.182</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="96" to="104" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Al-Chalabi, A.; van den Berg, L.H.; Veldink, J. Gene discovery in amyotrophic lateral sclerosis: Implications for clinical management. Nat. Rev. Neurol. 2017, 13, 96-104. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Decoding ALS: From genes to mechanism</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Cleveland</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature20413</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">539</biblScope>
			<biblScope unit="page" from="197" to="206" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Taylor, J.P.; Brown, R.H.; Cleveland, D.W. Decoding ALS: From genes to mechanism. Nature 2016, 539, 197-206. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Diet and amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Morozova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">G</forename><surname>Weisskopf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Mccullough</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">L</forename><surname>Munger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">E</forename><surname>Calle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Thun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ascherio</surname></persName>
		</author>
		<idno type="DOI">10.1097/EDE.0b013e3181632c5d</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="324" to="337" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
	<note type="raw_reference">Morozova, N.; Weisskopf, M.G.; McCullough, M.L.; Munger, K.L.; Calle, E.E.; Thun, M.J.; Ascherio, A. Diet and amyotrophic lateral sclerosis. Epidemiology 2008, 19, 324-337. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The dual roles of immunity in ALS: Injury overrides protection</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Murdock</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Bender</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">M</forename><surname>Segal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L</forename><surname>Feldman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2015.02.017</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="1" to="12" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note type="raw_reference">Murdock, B.J.; Bender, D.E.; Segal, B.M.; Feldman, E.L. The dual roles of immunity in ALS: Injury overrides protection. Neurobiol. Dis. 2015, 77, 1-12. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Epidemiology of mild traumatic brain injury and neurodegenerative disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">C</forename><surname>Gardner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Yaffe</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mcn.2015.03.001</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Neurosci</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="75" to="80" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note type="raw_reference">Gardner, R.C.; Yaffe, K. Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol. Cell. Neurosci. 2015, 66, 75-80. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Lacorte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Ferrigno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Leoncini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Corbo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Boccia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Vanacore</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neubiorev.2016.04.007</idno>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Biobehav. Rev</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="61" to="79" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Lacorte, E.; Ferrigno, L.; Leoncini, E.; Corbo, M.; Boccia, S.; Vanacore, N. Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review. Neurosci. Biobehav. Rev. 2016, 66, 61-79. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Metals and neurodegenerative diseases. A systematic review</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">E</forename><surname>Cicero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Mostile</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Vasta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Rapisarda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">S</forename><surname>Signorelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ferrante</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zappia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nicoletti</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.envres.2017.07.048</idno>
	</analytic>
	<monogr>
		<title level="j">Environ. Res</title>
		<imprint>
			<biblScope unit="volume">159</biblScope>
			<biblScope unit="page" from="82" to="94" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Cicero, C.E.; Mostile, G.; Vasta, R.; Rapisarda, V.; Signorelli, S.S.; Ferrante, M.; Zappia, M.; Nicoletti, A. Metals and neurodegenerative diseases. A systematic review. Environ. Res. 2017, 159, 82-94. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Amyotrophic Lateral Sclerosis and Occupational Exposures: A Systematic Literature Review and Meta-Analyses</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L.-G</forename><surname>Gunnarsson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Bodin</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijerph15112371</idno>
	</analytic>
	<monogr>
		<title level="j">Int. J. Environ. Res. Public Health</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Gunnarsson, L.-G.; Bodin, L. Amyotrophic Lateral Sclerosis and Occupational Exposures: A Systematic Literature Review and Meta-Analyses. Int. J. Environ. Res. Public Health 2018, 15, 2371. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The role of mitochondria in amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">F</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">J</forename><surname>De Vos</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neulet.2017.06.052</idno>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">710</biblScope>
			<biblScope unit="page">132933</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Smith, E.F.; Shaw, P.J.; De Vos, K.J. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci. Lett. 2017, 710, 132933. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Takeda</surname></persName>
		</author>
		<idno type="DOI">10.1111/neup.12428</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropathology</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="72" to="81" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Takeda, T. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration. Neuropathology 2018, 38, 72-81. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Infectious agents and amyotrophic lateral sclerosis: Another piece of the puzzle of motor neuron degeneration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Castanedo-Vazquez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Bosque-Varela</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Sainz-Pelayo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Riancho</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00415-018-8919-3</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurol</title>
		<imprint>
			<biblScope unit="volume">266</biblScope>
			<biblScope unit="page" from="27" to="36" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Castanedo-Vazquez, D.; Bosque-Varela, P.; Sainz-Pelayo, A.; Riancho, J. Infectious agents and amyotrophic lateral sclerosis: Another piece of the puzzle of motor neuron degeneration. J. Neurol. 2019, 266, 27-36. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Hamidou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Marin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Lautrette</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Nicol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Camu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Corcia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M.-C</forename><surname>Arnes-Bes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Tranchant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Clavelou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Hannequin</surname></persName>
		</author>
		<idno type="DOI">10.1080/21678421.2017.1353098</idno>
	</analytic>
	<monogr>
		<title level="j">Amyotroph Lateral Scler. Front. Degener</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="519" to="527" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Hamidou, B.; Marin, B.; Lautrette, G.; Nicol, M.; Camu, W.; Corcia, P.; Arnes-Bes, M.-C.; Tranchant, C.; Clavelou, P.; Hannequin, D.; et al. Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment. Amyotroph Lateral Scler. Front. Degener 2017, 18, 519-527. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>Gordon</surname></persName>
		</author>
		<idno type="DOI">10.14336/AD.2013.0400295</idno>
	</analytic>
	<monogr>
		<title level="j">Aging Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="295" to="310" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note type="raw_reference">Gordon, P.H. Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials. Aging Dis. 2013, 4, 295-310. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2017.01005</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">1005</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Liu, J.; Wang, F. Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Front. Immunol. 2017, 8, 1005. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Interactions of innate and adaptive immunity in brain development and function</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Filiano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">P</forename><surname>Gadani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kipnis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainres.2014.07.050</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">1617</biblScope>
			<biblScope unit="page" from="18" to="27" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note type="raw_reference">Filiano, A.J.; Gadani, S.P.; Kipnis, J. Interactions of innate and adaptive immunity in brain development and function. Brain Res. 2015, 1617, 18-27. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">How neuroinflammation contributes to neurodegeneration</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">M</forename><surname>Ransohoff</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.aag2590</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="page" from="777" to="783" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Ransohoff, R.M. How neuroinflammation contributes to neurodegeneration. Science 2016, 353, 777-783. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Astrogliosis in amyotrophic lateral sclerosis: Role and therapeutic potential of astrocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Vargas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nurt.2010.05.012</idno>
	</analytic>
	<monogr>
		<title level="j">Neurotherapeutics</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="471" to="481" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note type="raw_reference">Vargas, M.R.; Johnson, J.A. Astrogliosis in amyotrophic lateral sclerosis: Role and therapeutic potential of astrocytes. Neurotherapeutics 2010, 7, 471-481. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Radford</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Morsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Rayner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">L</forename><surname>Pountney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">S</forename><surname>Chung</surname></persName>
		</author>
		<idno type="DOI">10.3389/fncel.2015.00414</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Cell. Neurosci</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">414</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Radford, R.A.; Morsch, M.; Rayner, S.L.; Cole, N.J.; Pountney, D.L.; Chung, R.S. The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia. Front. Cell. Neurosci. 2015, 9, 414. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Astrocytes from familial and sporadic ALS patients are toxic to motor neurons</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">M</forename><surname>Haidet-Phillips</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Hester</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Miranda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Frakes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Likhite</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Murtha</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">D</forename><surname>Foust</surname></persName>
		</author>
		<idno type="DOI">10.1038/nbt.1957</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Biotechnol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="824" to="828" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Haidet-Phillips, A.M.; Hester, M.E.; Miranda, C.J.; Meyer, K.; Braun, L.; Frakes, A.; Song, S.; Likhite, S.; Murtha, M.J.; Foust, K.D.; et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011, 29, 824-828. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Trias</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">H</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Si</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Varela</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ibarburu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kovacs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">C</forename><surname>Moura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Hermine</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci.insight.123249</idno>
	</analytic>
	<monogr>
		<title level="j">JCI Insight</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Trias, E.; King, P.H.; Si, Y.; Kwon, Y.; Varela, V.; Ibarburu, S.; Kovacs, M.; Moura, I.C.; Beckman, J.S.; Hermine, O.; et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight 2018, 3, e123249. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Glial cells in amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lasiene</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Yamanaka</surname></persName>
		</author>
		<idno type="DOI">10.1155/2011/718987</idno>
	</analytic>
	<monogr>
		<title level="j">Neurol. Res. Int</title>
		<imprint>
			<date type="published" when="2011" />
		</imprint>
	</monogr>
	<note type="raw_reference">Lasiene, J.; Yamanaka, K. Glial cells in amyotrophic lateral sclerosis. Neurol. Res. Int. 2011, 2011, 718987. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Neurotoxic reactive astrocytes are induced by activated microglia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Liddelow</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Guttenplan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">E</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">C</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Bohlen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Schirmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">E</forename><surname>Münch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W.-S</forename><surname>Chung</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">C</forename><surname>Peterson</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature21029</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">541</biblScope>
			<biblScope unit="page" from="481" to="487" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Liddelow, S.A.; Guttenplan, K.A.; Clarke, L.E.; Bennett, F.C.; Bohlen, C.J.; Schirmer, L.; Bennett, M.L.; Münch, A.E.; Chung, W.-S.; Peterson, T.C.; et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017, 541, 481-487. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer&apos;s Disease, Parkinson&apos;s Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Cheng</surname></persName>
		</author>
		<idno type="DOI">10.3389/fimmu.2018.02122</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Immunol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note type="raw_reference">Chen, X.; Hu, Y.; Cao, Z.; Liu, Q.; Cheng, Y. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer&apos;s Disease, Parkinson&apos;s Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Front. Immunol. 2018, 9, 2122. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Fan</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnins.2019.00574</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Neurosci</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<date type="published" when="2019" />
		</imprint>
	</monogr>
	<note type="raw_reference">Chen, Y.; Xia, K.; Chen, L.; Fan, D. Increased Interleukin-6 Levels in the Astrocyte-Derived Exosomes of Sporadic Amyotrophic Lateral Sclerosis Patients. Front. Neurosci. 2019, 13, 574. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Oeckl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Weydt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Steinacker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Anderl-Straub</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Nordin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">E</forename><surname>Volk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Diehl-Schmid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">M</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kornhuber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Danek</surname></persName>
		</author>
		<idno type="DOI">10.1136/jnnp-2018-318868</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurol. Neurosurg. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">90</biblScope>
			<biblScope unit="page" from="4" to="10" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Oeckl, P.; Weydt, P.; Steinacker, P.; Anderl-Straub, S.; Nordin, F.; Volk, A.E.; Diehl-Schmid, J.; Andersen, P.M.; Kornhuber, J.; Danek, A.; et al. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase. J. Neurol. Neurosurg. Psychiatry 2019, 90, 4-10. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">G</forename><surname>Hooten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Beers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Appel</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13311-014-0329-3</idno>
	</analytic>
	<monogr>
		<title level="j">Neurotherapeutics</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="364" to="375" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Hooten, K.G.; Beers, D.R.; Zhao, W.; Appel, S.H. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics 2015, 12, 364-375. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Graves</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Fiala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">A V</forename><surname>Dinglasan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">Q</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sayre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Chiappelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Van Kooten</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">V</forename><surname>Vinters</surname></persName>
		</author>
		<idno type="DOI">10.1080/14660820410020286</idno>
	</analytic>
	<monogr>
		<title level="j">Amyotroph. Lateral Scler. Other Mot. Neuron Disord</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="213" to="219" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Graves, M.C.; Fiala, M.; Dinglasan, L.A.V.; Liu, N.Q.; Sayre, J.; Chiappelli, F.; van Kooten, C.; Vinters, H.V. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2004, 5, 213-219. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Bettelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Carrier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Korn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">B</forename><surname>Strom</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Oukka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">L</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">K</forename><surname>Kuchroo</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature04753</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">441</biblScope>
			<biblScope unit="page" from="235" to="238" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
	<note type="raw_reference">Bettelli, E.; Carrier, Y.; Gao, W.; Korn, T.; Strom, T.B.; Oukka, M.; Weiner, H.L.; Kuchroo, V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441, 235-238. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">M</forename><surname>Chiu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Kosaras</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Tsiftsoglou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">K</forename><surname>Vartanian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Carroll</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0804610105</idno>
	</analytic>
	<monogr>
		<title level="m">Proc. Natl. Acad. Sci</title>
		<meeting>Natl. Acad. Sci<address><addrLine>USA</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2008" />
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="17913" to="17918" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Chiu, I.M.; Chen, A.; Zheng, Y.; Kosaras, B.; Tsiftsoglou, S.A.; Vartanian, T.K.; Brown, R.H.; Carroll, M.C. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc. Natl. Acad. Sci. USA 2008, 105, 17913-17918. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Beers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Henkel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Appel</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2012.07.008</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="418" to="428" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Zhao, W.; Beers, D.R.; Liao, B.; Henkel, J.S.; Appel, S.H. Regulatory T lymphocytes from ALS mice suppress microglia and effector T lymphocytes through different cytokine-mediated mechanisms. Neurobiol. Dis. 2012, 48, 418-428. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Henkel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Beers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">L</forename><surname>Rivera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Toennis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Appel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">H</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">Z</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">H</forename><surname>Appel</surname></persName>
		</author>
		<idno type="DOI">10.1002/emmm.201201544</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO Mol. Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="64" to="79" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Henkel, J.S.; Beers, D.R.; Wen, S.; Rivera, A.L.; Toennis, K.M.; Appel, J.E.; Zhao, W.; Moore, D.H.; Powell, S.Z.; Appel, S.H. Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol. Med. 2013, 5, 64-79. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Oxidative stress: A concept in redox biology and medicine</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Sies</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.redox.2015.01.002</idno>
	</analytic>
	<monogr>
		<title level="j">Redox Biol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="180" to="183" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Sies, H. Oxidative stress: A concept in redox biology and medicine. Redox Biol. 2015, 4, 180-183. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys) Regulation</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>D'ambrosi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Cozzolino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">T</forename><surname>Carrì</surname></persName>
		</author>
		<idno type="DOI">10.1089/ars.2017.7271</idno>
	</analytic>
	<monogr>
		<title level="j">Antioxid. Redox Signal</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="15" to="36" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note type="raw_reference">D&apos;Ambrosi, N.; Cozzolino, M.; Carrì, M.T. Neuroinflammation in Amyotrophic Lateral Sclerosis: Role of Redox (dys) Regulation. Antioxid. Redox Signal. 2018, 29, 15-36. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Pollari</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Goldsteins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Bart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Koistinaho</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Giniatullin</surname></persName>
		</author>
		<idno type="DOI">10.3389/fncel.2014.00131</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Cell. Neurosci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">131</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Pollari, E.; Goldsteins, G.; Bart, G.; Koistinaho, J.; Giniatullin, R. The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 2014, 8, 131. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Weiduschat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Hupf</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">J</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Mitsumoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Shungu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neulet.2014.04.020</idno>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">570</biblScope>
			<biblScope unit="page" from="102" to="107" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Weiduschat, N.; Mao, X.; Hupf, J.; Armstrong, N.; Kang, G.; Lange, D.J.; Mitsumoto, H.; Shungu, D.C. Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique. Neurosci. Lett. 2014, 570, 102-107. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">J</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">W</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Unger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Q</forename><surname>Trojanowski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1038/emboj.2011.471</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="1241" to="1252" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note type="raw_reference">Cohen, T.J.; Hwang, A.W.; Unger, T.; Trojanowski, J.Q.; Lee, V.M.Y. Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J. 2012, 31, 1241-1252. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Duan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroscience.2010.06.018</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="page" from="1621" to="1629" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note type="raw_reference">Duan, W.; Li, X.; Shi, J.; Guo, Y.; Li, Z.; Li, C. Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell. Neuroscience 2010, 169, 1621-1629. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Shodai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Morimura</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Uchida</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Ayaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kitazawa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Shirouzu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kigawa</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M113.451849</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="14886" to="14905" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note type="raw_reference">Shodai, A.; Morimura, T.; Ido, A.; Uchida, T.; Ayaki, T.; Takahashi, R.; Kitazawa, S.; Suzuki, S.; Shirouzu, M.; Kigawa, T.; et al. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43). J. Biol. Chem. 2013, 288, 14886-14905. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Petri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Körner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kiaei</surname></persName>
		</author>
		<idno type="DOI">10.1155/2012/878030</idno>
	</analytic>
	<monogr>
		<title level="j">Neurol. Res. Int</title>
		<imprint>
			<biblScope unit="volume">878030</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Petri, S.; Körner, S.; Kiaei, M. Nrf2/ARE Signaling Pathway: Key Mediator in Oxidative Stress and Potential Therapeutic Target in ALS. Neurol. Res. Int. 2012, 2012, 878030. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Vargas</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pehar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Cassina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">S</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Barbeito</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-4159.2006.03742.x</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="687" to="696" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Vargas, M.R.; Pehar, M.; Cassina, P.; Beckman, J.S.; Barbeito, L. Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J. Neurochem. 2006, 97, 687-696. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Neymotin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">Y</forename><surname>Calingasan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Wille</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Naseri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Petri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Damiano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">T</forename><surname>Liby</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Risingsong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Sporn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.freeradbiomed.2011.03.027</idno>
	</analytic>
	<monogr>
		<title level="j">Biol. Med</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="88" to="96" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Neymotin, A.; Calingasan, N.Y.; Wille, E.; Naseri, N.; Petri, S.; Damiano, M.; Liby, K.T.; Risingsong, R.; Sporn, M.; Beal, M.F.; et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2011, 51, 88-96. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">R</forename><surname>Wiedemann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Manfredi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Mawrin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">F</forename><surname>Beal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Schon</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.0022-3042.2001.00731.x</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="616" to="625" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
	<note type="raw_reference">Wiedemann, F.R.; Manfredi, G.; Mawrin, C.; Beal, M.F.; Schon, E.A. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 2002, 80, 616-625. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Ghiasi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Hosseinkhani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Noori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Nafissi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Khajeh</surname></persName>
		</author>
		<idno type="DOI">10.1179/1743132812Y.0000000012</idno>
	</analytic>
	<monogr>
		<title level="j">Neurol. Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="297" to="303" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note type="raw_reference">Ghiasi, P.; Hosseinkhani, S.; Noori, A.; Nafissi, S.; Khajeh, K. Mitochondrial complex I deficiency and ATP/ADP ratio in lymphocytes of amyotrophic lateral sclerosis patients. Neurol. Res. 2012, 34, 297-303. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Israelson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Arbel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Da Cruz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Ilieva</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Yamanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Shoshan-Barmatz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">W</forename><surname>Cleveland</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2010.07.019</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="575" to="587" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note type="raw_reference">Israelson, A.; Arbel, N.; Da Cruz, S.; Ilieva, H.; Yamanaka, K.; Shoshan-Barmatz, V.; Cleveland, D.W. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 2010, 67, 575-587. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">NAD+ and sirtuins in aging and disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Imai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Guarente</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tcb.2014.04.002</idno>
	</analytic>
	<monogr>
		<title level="j">Trends Cell Biol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="464" to="471" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Imai, S.; Guarente, L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014, 24, 464-471. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">SIRT3 regulation of mitochondrial oxidative stress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Bause</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Haigis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.exger.2012.08.007</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Gerontol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="634" to="639" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note type="raw_reference">Bause, A.S.; Haigis, M.C. SIRT3 regulation of mitochondrial oxidative stress. Exp. Gerontol. 2013, 48, 634-639. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J.-R.; Soon</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Kang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainres.2012.09.022</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">1483</biblScope>
			<biblScope unit="page" from="112" to="117" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note type="raw_reference">Han, S.; Choi, J.-R.; Soon Shin, K.; Kang, S.J. Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice. Brain Res. 2012, 1483, 112-117. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">SIRT1 deacetylase in aging-induced neuromuscular degeneration and amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">Z</forename><surname>Herskovits</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Hunter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Maxwell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Pereira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">A</forename><surname>Whittaker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Valdez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">P</forename><surname>Guarente</surname></persName>
		</author>
		<idno type="DOI">10.1111/acel.12839</idno>
	</analytic>
	<monogr>
		<title level="j">Aging Cell</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Herskovits, A.Z.; Hunter, T.A.; Maxwell, N.; Pereira, K.; Whittaker, C.A.; Valdez, G.; Guarente, L.P. SIRT1 deacetylase in aging-induced neuromuscular degeneration and amyotrophic lateral sclerosis. Aging Cell 2018, 17, e12839. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Sirt1 and the Mitochondria</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">L</forename><surname>Tang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cells</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="87" to="95" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Tang, B.L. Sirt1 and the Mitochondria. Mol. Cells 2016, 39, 87-95. [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Thau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Knippenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Körner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">J</forename><surname>Rath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Dengler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Petri</surname></persName>
		</author>
		<idno type="DOI">10.1097/NEN.0b013e318275df4b</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neuropathol. Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="1064" to="1074" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note type="raw_reference">Thau, N.; Knippenberg, S.; Körner, S.; Rath, K.J.; Dengler, R.; Petri, S. Decreased mRNA expression of PGC-1α and PGC-1α-regulated factors in the SOD1G93A ALS mouse model and in human sporadic ALS. J. Neuropathol. Exp. Neurol. 2012, 71, 1064-1074. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Bossy-Wetzel, E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1α</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Kincaid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Bossy</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2012.07.004</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="72" to="81" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Song, W.; Song, Y.; Kincaid, B.; Bossy, B.; Bossy-Wetzel, E. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1α. Neurobiol. Dis. 2013, 51, 72-81. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">SIRT3 and mitochondrial metabolism in neurodegenerative diseases</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Salvatori</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Valle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ferri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Carrì</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuint.2017.04.012</idno>
	</analytic>
	<monogr>
		<title level="j">Neurochem. Int</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="184" to="192" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Salvatori, I.; Valle, C.; Ferri, A.; Carrì, M.T. SIRT3 and mitochondrial metabolism in neurodegenerative diseases. Neurochem. Int. 2017, 109, 184-192. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Sirtuins as therapeutic targets of ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Pasinetti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">E</forename><surname>Bilski</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="DOI">10.1038/cr.2013.94</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="1073" to="1074" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note type="raw_reference">Pasinetti, G.M.; Bilski, A.E.; Zhao, W. Sirtuins as therapeutic targets of ALS. Cell Res. 2013, 23, 1073-1074. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">A</forename><surname>Harlan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pehar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Beeson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">C</forename><surname>Beeson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Vargas</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M115.698779</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="10836" to="10846" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Harlan, B.A.; Pehar, M.; Sharma, D.R.; Beeson, G.; Beeson, C.C.; Vargas, M.R. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1). J. Biol. Chem. 2016, 291, 10836-10846. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: A randomized, double-blind, placebo-controlled human pilot study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>De La Rubia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Drehmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">L</forename><surname>Platero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Benlloch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Caplliure-Llopis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Villaron-Casales</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>De Bernardo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Alarcón</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Fuente</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Carrera</surname></persName>
		</author>
		<idno type="DOI">10.1080/21678421.2018.1536152</idno>
	</analytic>
	<monogr>
		<title level="j">Amyotroph Lateral Scler. Front. Degener</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="115" to="122" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
	<note type="raw_reference">De la Rubia, J.E.; Drehmer, E.; Platero, J.L.; Benlloch, M.; Caplliure-Llopis, J.; Villaron-Casales, C.; de Bernardo, N.; AlarcÓn, J.; Fuente, C.; Carrera, S.; et al. Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: A randomized, double-blind, placebo-controlled human pilot study. Amyotroph Lateral Scler. Front. Degener. 2019, 20, 115-122. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Nicotinamide riboside is uniquely and orally bioavailable in mice and humans</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A J</forename><surname>Trammell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">S</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">J</forename><surname>Weidemann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Redpath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Jaksch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">W</forename><surname>Dellinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">D</forename><surname>Abel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Migaud</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Brenner</surname></persName>
		</author>
		<idno type="DOI">10.1038/ncomms12948</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Commun</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Trammell, S.A.J.; Schmidt, M.S.; Weidemann, B.J.; Redpath, P.; Jaksch, F.; Dellinger, R.W.; Li, Z.; Abel, E.D.; Migaud, M.E.; Brenner, C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat. Commun. 2016, 7, 12948. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Ottenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">F</forename><surname>Sferrazza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Hubbs</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Fallahi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Rumbaugh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">F</forename><surname>Brantley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">I</forename><surname>Lasmézas</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awv002</idno>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="page" from="992" to="1008" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note type="raw_reference">Zhou, M.; Ottenberg, G.; Sferrazza, G.F.; Hubbs, C.; Fallahi, M.; Rumbaugh, G.; Brantley, A.F.; Lasmézas, C.I. Neuronal death induced by misfolded prion protein is due to NAD+ depletion and can be relieved in vitro and in vivo by NAD+ replenishment. Brain 2015, 138, 992-1008. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T.-Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y.-F</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W.-W</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Viollet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y.-C</forename><surname>Rui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q.-W</forename><surname>Zhai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D.-F</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C.-Y</forename><surname>Miao</surname></persName>
		</author>
		<idno type="DOI">10.1002/ana.22236</idno>
	</analytic>
	<monogr>
		<title level="j">Ann. Neurol</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="360" to="374" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Wang, P.; Xu, T.-Y.; Guan, Y.-F.; Tian, W.-W.; Viollet, B.; Rui, Y.-C.; Zhai, Q.-W.; Su, D.-F.; Miao, C.-Y. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann. Neurol. 2011, 69, 360-374. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">SARM1 activation triggers axon degeneration locally via NAD + destruction</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Gerdts</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Brace</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Milbrandt</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1258366</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">348</biblScope>
			<biblScope unit="page" from="453" to="457" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Gerdts, J.; Brace, E.J.; Sasaki, Y.; DiAntonio, A.; Milbrandt, J. SARM1 activation triggers axon degeneration locally via NAD + destruction. Science 2015, 348, 453-457. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">How mitochondria produce reactive oxygen species</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">P</forename><surname>Murphy</surname></persName>
		</author>
		<idno type="DOI">10.1042/BJ20081386</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">417</biblScope>
			<biblScope unit="page" from="1" to="13" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Murphy, M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417, 1-13. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">B</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S.-Y</forename><surname>Jang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">T</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U.-W</forename><surname>Jeoun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">S</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">S</forename><surname>Hwang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Cells</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="503" to="514" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Song, S.B.; Jang, S.-Y.; Kang, H.T.; Wei, B.; Jeoun, U.-W.; Yoon, G.S.; Hwang, E.S. Modulation of Mitochondrial Membrane Potential and ROS Generation by Nicotinamide in a Manner Independent of SIRT1 and Mitophagy. Mol. Cells 2017, 40, 503-514.</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Pterostilbene: Biomedical applications</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Estrela</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ortega</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mena</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Asensi</surname></persName>
		</author>
		<idno type="DOI">10.3109/10408363.2013.805182</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Rev. Clin. Lab. Sci</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="65" to="78" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Estrela, J.M.; Ortega, A.; Mena, S.; Rodriguez, M.L.; Asensi, M. Pterostilbene: Biomedical applications. Crit Rev. Clin. Lab. Sci. 2013, 50, 65-78. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Mancuso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Del Valle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Modol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Granado-Serrano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Ramirez-Núñez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Pallás</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Portero-Otin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Osta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Navarro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurotherapeutics</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="419" to="432" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Mancuso, R.; del Valle, J.; Modol, L.; Martinez, A.; Granado-Serrano, A.B.; Ramirez-Núñez, O.; Pallás, M.; Portero-Otin, M.; Osta, R.; Navarro, X. Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice. Neurotherapeutics 2014, 11, 419-432.</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1G93A mouse model of amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Le</surname></persName>
		</author>
		<idno type="DOI">10.1155/2014/483501</idno>
	</analytic>
	<monogr>
		<title level="j">Biomed Res. Int</title>
		<imprint>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Song, L.; Chen, L.; Zhang, X.; Li, J.; Le, W. Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1G93A mouse model of amyotrophic lateral sclerosis. Biomed Res. Int. 2014, 2014. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Yue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Qu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainres.2016.04.048</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">1643</biblScope>
			<biblScope unit="page" from="70" to="79" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Wang, B.; Liu, H.; Yue, L.; Li, X.; Zhao, L.; Yang, X.; Wang, X.; Yang, Y.; Qu, Y. Neuroprotective effects of pterostilbene against oxidative stress injury: Involvement of nuclear factor erythroid 2-related factor 2 pathway. Brain Res. 2016, 1643, 70-79. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Pterostilbene Attenuates Early Brain Injury Following Subarachnoid Hemorrhage via Inhibition of the NLRP3 Inflammasome and Nox2-Related Oxidative Stress</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Yue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Deng</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12035-016-0108-8</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="5928" to="5940" />
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Liu, H.; Zhao, L.; Yue, L.; Wang, B.; Li, X.; Guo, H.; Ma, Y.; Yao, C.; Gao, L.; Deng, J.; et al. Pterostilbene Attenuates Early Brain Injury Following Subarachnoid Hemorrhage via Inhibition of the NLRP3 Inflammasome and Nox2-Related Oxidative Stress. Mol. Neurobiol. 2017, 54, 5928-5940. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Deora</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">A</forename><surname>Albornoz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Mcalary</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">J</forename><surname>Jagaraj</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A B</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Atkin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Yerbury</surname></persName>
		</author>
		<idno type="DOI">10.1002/glia.23728</idno>
	</analytic>
	<monogr>
		<title level="j">Glia</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="407" to="421" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
	<note type="raw_reference">Deora, V.; Lee, J.D.; Albornoz, E.A.; McAlary, L.; Jagaraj, C.J.; Robertson, A.A.B.; Atkin, J.D.; Cooper, M.A.; Schroder, K.; Yerbury, J.J.; et al. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 2020, 68, 407-421. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">L</forename><surname>Circu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">Y</forename><surname>Aw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Glutathione</surname></persName>
		</author>
		<idno type="DOI">10.1080/10715760802317663</idno>
	</analytic>
	<monogr>
		<title level="j">Free Radic. Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="689" to="706" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Circu, M.L.; Aw, T.Y. Glutathione and apoptosis. Free Radic. Res. 2008, 42, 689-706. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Mytilineou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Kokotos Leonardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">C</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Jamindar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">W</forename><surname>Olanow</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1471-4159.1999.0730112.x</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="112" to="119" />
			<date type="published" when="1999" />
		</imprint>
	</monogr>
	<note type="raw_reference">Mytilineou, C.; Kokotos Leonardi, E.T.; Kramer, B.C.; Jamindar, T.; Olanow, C.W. Glial cells mediate toxicity in glutathione-depleted mesencephalic cultures. J. Neurochem. 1999, 73, 112-119. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J.-W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P.-Y</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H.-G</forename><surname>Zang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z.-J</forename><surname>Kou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z.-W</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W.-J</forename><surname>Yan</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbr.2016.04.045</idno>
	</analytic>
	<monogr>
		<title level="j">Behav. Brain Res</title>
		<imprint>
			<biblScope unit="volume">309</biblScope>
			<biblScope unit="page" from="1" to="8" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Xue, F.; Huang, J.-W.; Ding, P.-Y.; Zang, H.-G.; Kou, Z.-J.; Li, T.; Fan, J.; Peng, Z.-W.; Yan, W.-J. Nrf2/antioxidant defense pathway is involved in the neuroprotective effects of Sirt1 against focal cerebral ischemia in rats after hyperbaric oxygen preconditioning. Behav. Brain Res. 2016, 309, 1-8. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Mimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Miyazaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Morimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kurata</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Satoh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Ikeda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Abe</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainres.2011.12.064</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">1446</biblScope>
			<biblScope unit="page" from="109" to="118" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
	<note type="raw_reference">Mimoto, T.; Miyazaki, K.; Morimoto, N.; Kurata, T.; Satoh, K.; Ikeda, Y.; Abe, K. Impaired antioxydative Keap1/Nrf2 system and the downstream stress protein responses in the motor neuron of ALS model mice. Brain Res. 2012, 1446, 109-118. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Di</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Dong</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10495-016-1258-x</idno>
	</analytic>
	<monogr>
		<title level="j">Apoptosis</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="905" to="916" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Cheng, Y.; Di, S.; Fan, C.; Cai, L.; Gao, C.; Jiang, P.; Hu, W.; Ma, Z.; Jiang, S.; Dong, Y.; et al. SIRT1 activation by pterostilbene attenuates the skeletal muscle oxidative stress injury and mitochondrial dysfunction induced by ischemia reperfusion injury. Apoptosis 2016, 21, 905-916. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">SIRT1-mediated deacetylation of PGC1α attributes to the protection of curcumin against glutamate excitotoxicity in cortical neurons</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Jia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2016.08.132</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">478</biblScope>
			<biblScope unit="page" from="1376" to="1381" />
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Jia, N.; Sun, Q.; Su, Q.; Chen, G. SIRT1-mediated deacetylation of PGC1α attributes to the protection of curcumin against glutamate excitotoxicity in cortical neurons. Biochem. Biophys. Res. Commun. 2016, 478, 1376-1381. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K.-S</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="DOI">10.1155/2016/7296092</idno>
	</analytic>
	<monogr>
		<title level="j">Oxid. Med. Cell. Longev</title>
		<imprint>
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Xu, S.; Gao, Y.; Zhang, Q.; Wei, S.; Chen, Z.; Dai, X.; Zeng, Z.; Zhao, K.-S. SIRT1/3 Activation by Resveratrol Attenuates Acute Kidney Injury in a Septic Rat Model. Oxid. Med. Cell. Longev. 2016, 2016, 7296092. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Sirt3 protects cortical neurons against oxidative stress via regulating mitochondrial Ca2+ and mitochondrial biogenesis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S.-H</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y.-H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Rao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y.-F</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Fei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X.-F</forename><surname>Jiang</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijms150814591</idno>
	</analytic>
	<monogr>
		<title level="j">Int. J. Mol. Sci</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="14591" to="14609" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Dai, S.-H.; Chen, T.; Wang, Y.-H.; Zhu, J.; Luo, P.; Rao, W.; Yang, Y.-F.; Fei, Z.; Jiang, X.-F. Sirt3 protects cortical neurons against oxidative stress via regulating mitochondrial Ca2+ and mitochondrial biogenesis. Int. J. Mol. Sci. 2014, 15, 14591-14609. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Over-expression of the Sirt3 sirtuin Protects neuronally differentiated PC12 Cells from degeneration induced by oxidative stress and trophic withdrawal</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Shulyakova</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Sidorova-Darmos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">R</forename><surname>Mills</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Eubanks</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brainres.2014.08.066</idno>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">1587</biblScope>
			<biblScope unit="page" from="40" to="53" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Shulyakova, N.; Sidorova-Darmos, E.; Fong, J.; Zhang, G.; Mills, L.R.; Eubanks, J.H. Over-expression of the Sirt3 sirtuin Protects neuronally differentiated PC12 Cells from degeneration induced by oxidative stress and trophic withdrawal. Brain Res. 2014, 1587, 40-53. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">The adenine nucleotide translocator in apoptosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A.-S</forename><surname>Belzacq</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">L A</forename><surname>Vieira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Kroemer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Brenner</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0300-9084(02)01366-4</idno>
	</analytic>
	<monogr>
		<title level="j">Biochimie</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="167" to="176" />
			<date type="published" when="2002" />
		</imprint>
	</monogr>
	<note type="raw_reference">Belzacq, A.-S.; Vieira, H.L.A.; Kroemer, G.; Brenner, C. The adenine nucleotide translocator in apoptosis. Biochimie 2002, 84, 167-176. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Mitochondrial pathobiology in ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10863-011-9395-y</idno>
	</analytic>
	<monogr>
		<title level="j">J. Bioenerg. Biomembr</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="569" to="579" />
			<date type="published" when="2011" />
		</imprint>
	</monogr>
	<note type="raw_reference">Martin, L.J. Mitochondrial pathobiology in ALS. J. Bioenerg. Biomembr. 2011, 43, 569-579. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">The adenine nucleotide translocase: A central component of the mitochondrial permeability transition pore and key player in cell death</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">P</forename><surname>Halestrap</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Brenner</surname></persName>
		</author>
		<idno type="DOI">10.2174/0929867033457278</idno>
	</analytic>
	<monogr>
		<title level="j">Curr. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1507" to="1525" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
	<note type="raw_reference">Halestrap, A.P.; Brenner, C. The adenine nucleotide translocase: A central component of the mitochondrial permeability transition pore and key player in cell death. Curr. Med. Chem. 2003, 10, 1507-1525. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">The adenine nucleotide translocator: A target of nitric oxide, peroxynitrite, and 4-hydroxynonenal</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">L</forename><surname>Vieira</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">S</forename><surname>Belzacq</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Haouzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Bernassola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Jacotot</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">F</forename><surname>Ferri</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Hamel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">M</forename><surname>Bartle</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Melino</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.onc.1204575</idno>
	</analytic>
	<monogr>
		<title level="j">Oncogene</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="4305" to="4316" />
			<date type="published" when="2001" />
		</imprint>
	</monogr>
	<note type="raw_reference">Vieira, H.L.; Belzacq, A.S.; Haouzi, D.; Bernassola, F.; Cohen, I.; Jacotot, E.; Ferri, K.F.; El Hamel, C.; Bartle, L.M.; Melino, G.; et al. The adenine nucleotide translocator: A target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 2001, 20, 4305-4316. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">The mitochondrial permeability transition pore in motor neurons: Involvement in the pathobiology of ALS mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Gertz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">C</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Molkentin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Chang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.expneurol.2009.02.015</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Neurol</title>
		<imprint>
			<biblScope unit="volume">218</biblScope>
			<biblScope unit="page" from="333" to="346" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
	<note type="raw_reference">Martin, L.J.; Gertz, B.; Pan, Y.; Price, A.C.; Molkentin, J.D.; Chang, Q. The mitochondrial permeability transition pore in motor neurons: Involvement in the pathobiology of ALS mice. Exp. Neurol. 2009, 218, 333-346. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Schuler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Bossy-Wetzel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Green</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.275.10.7337</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="7337" to="7342" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
	<note type="raw_reference">Schuler, M.; Bossy-Wetzel, E.; Goldstein, J.C.; Fitzgerald, P.; Green, D.R. p53 induces apoptosis by caspase activation through mitochondrial cytochrome c release. J. Biol. Chem. 2000, 275, 7337-7342. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Itaman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M</forename><surname>Khalid-Janney</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Sherard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Dowell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Cairns</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Gitcho</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neulet.2018.04.053</idno>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">678</biblScope>
			<biblScope unit="page" from="8" to="15" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note type="raw_reference">Davis, S.A.; Itaman, S.; Khalid-Janney, C.M.; Sherard, J.A.; Dowell, J.A.; Cairns, N.J.; Gitcho, M.A. TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci. Lett. 2018, 678, 8-15. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Autophagy and mitophagy in ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">L F</forename><surname>Holzbaur</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2018.07.005</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="35" to="40" />
			<date type="published" when="2019" />
		</imprint>
	</monogr>
	<note type="raw_reference">Evans, C.S.; Holzbaur, E.L.F. Autophagy and mitophagy in ALS. Neurobiol. Dis. 2019, 122, 35-40. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Purtell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Palomo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Manfredi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Peng</surname></persName>
		</author>
		<idno type="DOI">10.1080/15548627.2019.1644076</idno>
	</analytic>
	<monogr>
		<title level="j">Autophagy</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="917" to="931" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
	<note type="raw_reference">Deng, Z.; Lim, J.; Wang, Q.; Purtell, K.; Wu, S.; Palomo, G.M.; Tan, H.; Manfredi, G.; Zhao, Y.; Peng, J.; et al. ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway. Autophagy 2020, 16, 917-931. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Intercellular glutamate signaling in the nervous system and beyond</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">E</forename><surname>Featherstone</surname></persName>
		</author>
		<idno type="DOI">10.1021/cn900006n</idno>
	</analytic>
	<monogr>
		<title level="j">ACS Chem. Neurosci</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="4" to="12" />
			<date type="published" when="2010" />
		</imprint>
	</monogr>
	<note type="raw_reference">Featherstone, D.E. Intercellular glutamate signaling in the nervous system and beyond. ACS Chem. Neurosci. 2010, 1, 4-12. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Mitochondrial glutathione depletion by glutamine in growing tumor cells. Free Radic</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Carretero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Obrador</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Pellicer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Pascual</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Estrela</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0891-5849(00)00392-0</idno>
	</analytic>
	<monogr>
		<title level="j">Biol. Med</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="913" to="923" />
			<date type="published" when="2000" />
		</imprint>
	</monogr>
	<note type="raw_reference">Carretero, J.; Obrador, E.; Pellicer, J.A.; Pascual, A.; Estrela, J.M. Mitochondrial glutathione depletion by glutamine in growing tumor cells. Free Radic. Biol. Med. 2000, 29, 913-923. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Shang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W.-Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">F</forename><surname>Au</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Kamiya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Barmada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Finkbeiner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Lui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">E</forename><surname>Carlton</surname></persName>
		</author>
		<idno type="DOI">10.1172/JCI72723</idno>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Investig</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="981" to="999" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Qiu, H.; Lee, S.; Shang, Y.; Wang, W.-Y.; Au, K.F.; Kamiya, S.; Barmada, S.J.; Finkbeiner, S.; Lui, H.; Carlton, C.E.; et al. ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J. Clin. Investig. 2014, 124, 981-999. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Sproviero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>La Salvia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Giannini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Crippa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Gagliardi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Bernuzzi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Diamanti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ceroni</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Pansarasa</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Poletti</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnins.2018.00487</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Neurosci</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Sproviero, D.; La Salvia, S.; Giannini, M.; Crippa, V.; Gagliardi, S.; Bernuzzi, S.; Diamanti, L.; Ceroni, M.; Pansarasa, O.; Poletti, A.; et al. Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients. Front. Neurosci. 2018, 12, 487. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">I</forename><surname>Bruijn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">W</forename><surname>Becher</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">L</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">A</forename><surname>Jenkins</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">G</forename><surname>Copeland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">S</forename><surname>Sisodia</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Rothstein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">R</forename><surname>Borchelt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">L</forename><surname>Price</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0896-6273(00)80272-X</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="327" to="338" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
	<note type="raw_reference">Bruijn, L.I.; Becher, M.W.; Lee, M.K.; Anderson, K.L.; Jenkins, N.A.; Copeland, N.G.; Sisodia, S.S.; Rothstein, J.D.; Borchelt, D.R.; Price, D.L.; et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997, 18, 327-338. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">The multi-dimensional roles of astrocytes in ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Yamanaka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Komine</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neures.2017.09.011</idno>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Res</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="31" to="38" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Yamanaka, K.; Komine, O. The multi-dimensional roles of astrocytes in ALS. Neurosci. Res. 2018, 126, 31-38. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">U</forename><surname>Neniskyte</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Vilalta</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">C</forename><surname>Brown</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.febslet.2014.05.046</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">588</biblScope>
			<biblScope unit="page" from="2952" to="2956" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Neniskyte, U.; Vilalta, A.; Brown, G.C. Tumour necrosis factor alpha-induced neuronal loss is mediated by microglial phagocytosis. FEBS Lett. 2014, 588, 2952-2956. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Minich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Riemer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Wielinga</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Wijnholds</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Dringen</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1471-4159.2006.03737.x</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="373" to="384" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
	<note type="raw_reference">Minich, T.; Riemer, J.; Schulz, J.B.; Wielinga, P.; Wijnholds, J.; Dringen, R. The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J. Neurochem. 2006, 97, 373-384. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Calcium-mediated mechanisms in chemically induced cell death</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Nicotera</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Bellomo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Orrenius</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.pa.32.040192.002313</idno>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Pharmacol. Toxicol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="449" to="470" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
	<note type="raw_reference">Nicotera, P.; Bellomo, G.; Orrenius, S. Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Toxicol. 1992, 32, 449-470. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">High yield extraction of pure spinal motor neurons, astrocytes and microglia from single embryo and adult mouse spinal cord</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M.-J</forename><surname>Beaudet</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Cadau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Blais</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Bellenfant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Gros-Louis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Berthod</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep16763</idno>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note type="raw_reference">Beaudet, M.-J.; Yang, Q.; Cadau, S.; Blais, M.; Bellenfant, S.; Gros-Louis, F.; Berthod, F. High yield extraction of pure spinal motor neurons, astrocytes and microglia from single embryo and adult mouse spinal cord. Sci. Rep. 2015, 5, 16763. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Obrador</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Navarro</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Mompo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Asensi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Pellicer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Estrela</surname></persName>
		</author>
		<idno type="DOI">10.1042/bj3250183</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">325</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="183" to="189" />
			<date type="published" when="1997" />
		</imprint>
	</monogr>
	<note type="raw_reference">Obrador, E.; Navarro, J.; Mompo, J.; Asensi, M.; Pellicer, J.A.; Estrela, J.M. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo. Biochem. J. 1997, 325 Pt 1, 183-189. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Benlloch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mena</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Ferrer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Obrador</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Asensi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Pellicer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Carretero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Ortega</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Estrela</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M507471200</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="page" from="69" to="79" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
	<note type="raw_reference">Benlloch, M.; Mena, S.; Ferrer, P.; Obrador, E.; Asensi, M.; Pellicer, J.A.; Carretero, J.; Ortega, A.; Estrela, J.M. Bcl-2 and Mn-SOD antisense oligodeoxynucleotides and a glutamine-enriched diet facilitate elimination of highly resistant B16 melanoma cells by tumor necrosis factor-alpha and chemotherapy. J. Biol. Chem. 2006, 281, 69-79. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">UV-Assay with Pyruvate and NADH</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">U</forename><surname>Bergmeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Bernt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Methods of Enzymatic Analysis</title>
		<meeting><address><addrLine>Cambridge, MA, USA</addrLine></address></meeting>
		<imprint>
			<publisher>Academic Press</publisher>
			<date type="published" when="1974" />
			<biblScope unit="page" from="574" to="579" />
		</imprint>
	</monogr>
	<note>2nd ed.; Bergmeyer, H.U.</note>
	<note type="raw_reference">Bergmeyer, H.U.; Bernt, E. UV-Assay with Pyruvate and NADH. In Methods of Enzymatic Analysis, 2nd ed.; Bergmeyer, H.U., Ed.; Academic Press: Cambridge, MA, USA, 1974; pp. 574-579.</note>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: An endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Obrador</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">L</forename><surname>Valles</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Benlloch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Sirerol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Pellicer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Alcácer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A</forename><surname>Coronado</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>.-F.; Estrela</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0096466</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note>e96466. [CrossRef. PubMed</note>
	<note type="raw_reference">Obrador, E.; Valles, S.L.; Benlloch, M.; Sirerol, J.A.; Pellicer, J.A.; Alcácer, J.; Coronado, J.A.-F.; Estrela, J.M. Glucocorticoid receptor knockdown decreases the antioxidant protection of B16 melanoma cells: An endocrine system-related mechanism that compromises metastatic cell resistance to vascular endothelium-induced tumor cytotoxicity. PLoS ONE 2014, 9, e96466. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b102">
	<monogr>
		<title level="m" type="main">Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">G</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">D</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">H</forename><surname>Moore</surname></persName>
		</author>
		<idno type="DOI">10.1002/14651858.CD001447.pub3</idno>
		<imprint/>
	</monogr>
	<note>Rev. 2012, CD001447. [CrossRef. PubMed</note>
	<note type="raw_reference">Miller, R.G.; Mitchell, J.D.; Moore, D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. 2012, CD001447. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes)</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S.-J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K.-Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W.-C</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuroscience.2004.01.019</idno>
	</analytic>
	<monogr>
		<title level="j">Neuroscience</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="191" to="201" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Wang, S.-J.; Wang, K.-Y.; Wang, W.-C. Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience 2004, 125, 191-201. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? Front</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Petrov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Mansfield</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Moussy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Hermine</surname></persName>
		</author>
		<idno type="DOI">10.3389/fnagi.2017.00068</idno>
	</analytic>
	<monogr>
		<title level="j">Aging Neurosci</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">68</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note type="raw_reference">Petrov, D.; Mansfield, C.; Moussy, A.; Hermine, O. ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment? Front. Aging Neurosci. 2017, 9, 68. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b105">
	<monogr>
		<title level="m" type="main">Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Sawada</surname></persName>
		</author>
		<idno type="DOI">10.1080/14656566.2017.1319937</idno>
		<imprint>
			<date type="published" when="2017" />
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="735" to="738" />
		</imprint>
	</monogr>
	<note type="raw_reference">Sawada, H. Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin. Pharm. 2017, 18, 735-738. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b106">
	<monogr>
		<title level="m" type="main">Drug therapy: On the treatment trail for ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Scott</surname></persName>
		</author>
		<idno type="DOI">10.1038/550S120a</idno>
		<imprint>
			<date type="published" when="2017" />
			<biblScope unit="volume">550</biblScope>
			<biblScope unit="page" from="120" to="121" />
		</imprint>
	</monogr>
	<note type="raw_reference">Scott, A. Drug therapy: On the treatment trail for ALS. Nature 2017, 550, S120-S121. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Trias</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Ibarburu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Barreto-Núñez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Babdor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">T</forename><surname>Maciel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Guillo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Gros</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Dubreuil</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Díaz-Amarilla</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Cassina</surname></persName>
		</author>
		<idno type="DOI">10.1186/s12974-016-0620-9</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neuroinflamm</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<date type="published" when="2016" />
		</imprint>
	</monogr>
	<note type="raw_reference">Trias, E.; Ibarburu, S.; Barreto-Núñez, R.; Babdor, J.; Maciel, T.T.; Guillo, M.; Gros, L.; Dubreuil, P.; Díaz-Amarilla, P.; Cassina, P.; et al. Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis. J. Neuroinflamm. 2016, 13, 177. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b108">
	<monogr>
		<title level="m" type="main">Necrostatin-1 analogues: Critical issues on the specificity, activity and in vivo use in experimental disease models</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Duprez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Grootjans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Cauwels</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Nerinckx</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">B</forename><surname>Duhadaway</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Goossens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Roelandt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Van Hauwermeiren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Libert</surname></persName>
		</author>
		<idno type="DOI">10.1038/cddis.2012.176</idno>
		<imprint/>
	</monogr>
	<note>Cell Death Dis. 2012, 3, e437. [CrossRef</note>
	<note type="raw_reference">Takahashi, N.; Duprez, L.; Grootjans, S.; Cauwels, A.; Nerinckx, W.; DuHadaway, J.B.; Goossens, V.; Roelandt, R.; Van Hauwermeiren, F.; Libert, C.; et al. Necrostatin-1 analogues: Critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 2012, 3, e437. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Necroptosis drives motor neuron death in models of both sporadic and familial ALS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">B</forename><surname>Re</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Le Verche</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">W</forename><surname>Amoroso</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Politi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Phani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Ikiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Koolen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Nagata</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2014.01.011</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="1001" to="1008" />
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Re, D.B.; Le Verche, V.; Yu, C.; Amoroso, M.W.; Politi, K.A.; Phani, S.; Ikiz, B.; Hoffmann, L.; Koolen, M.; Nagata, T.; et al. Necroptosis drives motor neuron death in models of both sporadic and familial ALS. Neuron 2014, 81, 1001-1008. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">C</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Gaillard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>De Boer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Appeldoorn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Dorland</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">R</forename><surname>Sibson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">C</forename><surname>Anthony</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">B</forename><surname>Stolp</surname></persName>
		</author>
		<idno type="DOI">10.1186/2051-5960-2-66</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol. Commun</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page">66</biblScope>
			<date type="published" when="2014" />
		</imprint>
	</monogr>
	<note type="raw_reference">Evans, M.C.; Gaillard, P.J.; de Boer, M.; Appeldoorn, C.; Dorland, R.; Sibson, N.R.; Turner, M.R.; Anthony, D.C.; Stolp, H.B. CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2014, 2, 66. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Aspirin use associated with amyotrophic lateral sclerosis: A total population-based case-control study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C.-P</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F.-C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">.-W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">T</forename></persName>
		</author>
		<idno type="DOI">10.2188/jea.JE20140070</idno>
	</analytic>
	<monogr>
		<title level="j">J. Epidemiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="172" to="177" />
			<date type="published" when="2015" />
		</imprint>
	</monogr>
	<note type="raw_reference">Tsai, C.-P.; Lin, F.-C.; Lee, J.K.-W.; Lee, C.T.-C. Aspirin use associated with amyotrophic lateral sclerosis: A total population-based case-control study. J. Epidemiol. 2015, 25, 172-177. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Espejo-Porras</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fernández-Ruiz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>De Lago</surname></persName>
		</author>
		<idno type="DOI">10.1080/21678421.2018.1425454</idno>
	</analytic>
	<monogr>
		<title level="j">Amyotroph Lateral Scler. Front. Degener</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="377" to="386" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Espejo-Porras, F.; Fernández-Ruiz, J.; de Lago, E. Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler. Front. Degener 2018, 19, 377-386. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Moreau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Danel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">C</forename><surname>Devedjian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Grolez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Timmerman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Laloux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Petrault</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Gouel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Jonneaux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Dutheil</surname></persName>
		</author>
		<idno type="DOI">10.1089/ars.2017.7493</idno>
	</analytic>
	<monogr>
		<title level="j">Antioxid. Redox Signal</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="742" to="748" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Moreau, C.; Danel, V.; Devedjian, J.C.; Grolez, G.; Timmerman, K.; Laloux, C.; Petrault, M.; Gouel, F.; Jonneaux, A.; Dutheil, M.; et al. Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis? Antioxid. Redox Signal. 2018, 29, 742-748. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">M</forename><surname>Keefe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">S</forename><surname>Sheikh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijms18030548</idno>
	</analytic>
	<monogr>
		<title level="j">Int. J. Mol. Sci</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Keefe, K.M.; Sheikh, I.S.; Smith, G.M. Targeting Neurotrophins to Specific Populations of Neurons: NGF, BDNF, and NT-3 and Their Relevance for Treatment of Spinal Cord Injury. Int. J. Mol. Sci. 2017, 18, 548. [CrossRef] [PubMed]</note>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Mizuno</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Kurotani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Komatsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Kawanokuchi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><surname>Mitsuma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Suzumura</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuropharm.2003.09.009</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="404" to="411" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note type="raw_reference">Mizuno, T.; Kurotani, T.; Komatsu, Y.; Kawanokuchi, J.; Kato, H.; Mitsuma, N.; Suzumura, A. Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 2004, 46, 404-411. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Retroviruses and amyotrophic lateral sclerosis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Alfahad</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nath</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.antiviral.2013.05.006</idno>
	</analytic>
	<monogr>
		<title level="j">Antivir. Res</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="180" to="187" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
	<note type="raw_reference">Alfahad, T.; Nath, A. Retroviruses and amyotrophic lateral sclerosis. Antivir. Res. 2013, 99, 180-187. [CrossRef]</note>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">O</forename><surname>Kovalchuk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A A C</forename><surname>Heuberger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">T H M</forename><surname>Sleutjes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Ziagkos</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><surname>Van Den</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">H</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Ferguson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Franssen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">J</forename><surname>Groeneveld</surname></persName>
		</author>
		<idno type="DOI">10.1002/cpt.1096</idno>
	</analytic>
	<monogr>
		<title level="j">Clin. Pharmacol. Ther</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="1136" to="1145" />
			<date type="published" when="2018" />
		</imprint>
	</monogr>
	<note>PubMed</note>
	<note type="raw_reference">Kovalchuk, M.O.; Heuberger, J.A.A.C.; Sleutjes, B.T.H.M.; Ziagkos, D.; van den Berg, L.H.; Ferguson, T.A.; Franssen, H.; Groeneveld, G.J. Acute Effects of Riluzole and Retigabine on Axonal Excitability in Patients With Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. Clin. Pharmacol. Ther. 2018, 104, 1136-1145. [CrossRef] [PubMed]</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
